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Abstract  
Introduction: Spinal cord injured (SCI) patients have complex physical and psychological 
needs. Malnutrition (including under- and over- nutrition) is common after SCI, and is 
associated with adverse clinical outcomes such as increased risk of infection. To date, 
limited information is available to guide clinicians to identify, prevent and manage nutrition 
related complications in SCI patients. This gap in evidence has promoted a series of 
research studies addressing the following research aims: (1) To review and understand the 
variations in nutritional management in SCI centres (2) To evaluate whether currently 
implemented nutrition interventions (e.g probiotics use in preventing antibiotic associated 
diarrhoea (AAD) and Clostridium difficile infection (CDI) are evidence based and to 
discuss the potential barriers to good nutritional care in SCI centres; (3) To evaluate three 
original studies (bariatric surgery case studies; the use of oral nutritional supplement (ONS) 
and vitamin and minerals (VMS) and; the use of Lactobacillus casei Shirota (LcS) in 
preventing AAD. A total of seven peer-reviewed papers, utilising a range of mixed research 
methodologies (observational studies, case study, surveys, randomised-controlled trials and 
systematic review protocol) were undertaken to demonstrate the effectiveness of nutrition 
interventions in patients admitted to SCI centres with a critical commentary.  
Results: (1) Although most SCI centres use validated nutrition screening tool, the resource 
allocation for nutritional care appeared to be relatively limited; (2) Definition for AAD, 
CDI, under- / over-nutrition risk and choice of probiotics in preventing AAD / CDI are 
varied across SCI centres. (3) Three studies attempted to demonstrate an improvement in 
SCI patient’s quality of care are reported. These include: (i) the use of nutritional 
supplements in SCI patients at malnutrition-risk (undernutrition risk, serum albumin and 
haemoglobin level are predictors of oral nutrition supplements use); (ii) the first UK 
bariatric surgery in a morbidly obese SCI patient who failed all non-surgical interventions 
(an improvement in functional, anthropometrical and nutritional biochemistry was found 
after  surgery) and (iii) the use of probiotics in preventing antibiotic associated diarrhoea 
(AAD). (Lactobacillus casei Shirota was found to prevent AAD when compared to a 
control, 17.1% v 54.9%, p<0.01).  
Conclusion: Our studies suggest that resources allocated in SCI centres varied. Without 
sufficient nutritional resources in SCI centres,  malnutrition will be  under-detected and 
under-treated. In addition, carefully planned nutrition / dietetic interventions could improve 
outcomes in SCI patients if nutritional care is embedded in the SCI care-pathway. 
Development of clinical nutrition practice guidelines are warranted, and further well-
designed randomised controlled trails are required to confirm whether the effect of nutrition 
(and probiotic) intervention is cost- and clinically-effective.   
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Chapter 1 Introduction 
Overview 
Disease-related malnutrition is both a cause and consequence of disease, and as such, it 
cannot be eliminated. (Elia, 2003)  There is sound evidence from the literature that 
delivery of improvement in the quality of nutritional care significantly reduces adverse 
clinical outcomes such as harm whilst improving an individual’s quality of life and 
reducing morbidity and mortality (NICE, 2006a). The impact of malnutrition in spinal 
cord injury (SCI) patients is more evident as they tend to have a long hospital stay after 
acute injury (Wong et al, 2012a; Wong et al, 2013). After a SCI, patients are expected to 
transfer to a specialist SCI centres for ongoing rehabilitation before they can re-integrate 
into the community. It is not known how staff in SCI centres identify or manage 
malnutrition after SCI and this will consequently alter the clinical decisions made for 
the management and ultimately, may have an impact on clinical outcomes. SCI 
contributes to both sensory and functional impairments and greatly impairs activities of  
daily living for SCI patients. A multicentre study found that at least 45% of SCI patients 
were overweight and 15.3% were obese (Wong et al, 2012a). If malnutrition after SCI 
goes undetected and unmanaged, it could cause a significant problem, including longer 
hospital stay (Wong et al, 2013), increase risk of infections (Schneider et al, 2004) 
increase in-hospital mortality (Wong et al, 2013), pressure ulcers (Consortium of Spinal 
Cord Medicine, 2014) and the development of nutrition-related complications such as 
obesity and other cardio-metabolic complications (NICE, 2006a). 
 
Newly-injured SCI patients require anticoagulation therapy to prevent venous 
thromboembolism. This increases the risk of gastric ulcers, so patients often receive a 
proton pump inhibitor (PPI) to protect the stomach against this adverse effect. 
(Consortium for Spinal Cord Medicien, 2004) Literature reports show that patients on 
PPI have an increased risk of contracting Clostridium difficile infection (CDI) compared 
with patients who are not taking PPI (Tariq et al, 2017).  In addition, increased use of 
invasive devices such as urinary catheters increases the risk of adverse effects of 
antibiotic use, including CDI (Evans et al, 2008). In SCI patients, antibiotic associated 
diarrhoea (AAD) and / or CDI can contribute to or complicate any pressure ulcer 
management as it leads to moisture and bacteria that could potentially contaminate 
pressure ulcers.  Recurrent diarrhoea also depletes the body of electrolytes which are 
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key in wound healing, and chronic episodes lead to loss of micronutrients such as 
magnesium and zinc (Worth et al, 2016). The microbiota has an important role in 
human health. Changes in microbiota can confer resistance to or promote infection by 
pathogenic bacteria. Antibiotics have a profound impact on the microbiota that alters the 
nutritional landscape of the gut and can lead to the expansion of pathogenic populations. 
Therefore the interactions between the microbiota, probiotics, the host and pathogenic 
bacteria will produce strategies for manipulating the microbiota against AAD / CDI. 
(see section 1.6). 
 
1.1 Aims and objectives of the thesis  
To date, limited information is available to guided clinician to identify, prevent and 
manage nutrition related complications in SCI patients. This gap in the evidence 
promoted a series of research studies addressing the following research questions:  
 
- How would SCI centres identify patients at risk of malnutrition?  
- Are current nutrition intervention (e.g. oral nutrition supplement and vitamins 
and minerals supplements) evidence base?  
- Would nutrition intervention (e.g. probiotic) improve patient’s clinical outcome 
such as antibiotic associated diarrhoea (AAD)?  
 
The over arching hypothesis of this thesis was to review if implementing evidence 
based nutritional interventions could improve decision making and clinical outcomes of 
SCI patients through three specific aims. 
 
Aim 1: 
To review and understand the variations in nutritional management in SCI centres from 
the perspective of staff and SCI patients. 
  
Objectives: 
- To review their choice of nutrition screening tools for identifying malnutrition 
risk. 
- To discuss the variation in dietetic provision in SCI centres with reference to 
other multidisciplinary team members from wider allied health professionals. 
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- To generate expert opinion (knowledge, attitude and practice) in obesity 
management amongst SCI centres in the UK, Ireland, Belgium and the 
Netherlands. 
 
Aim 2: 
To evaluate whether currently implemented nutrition interventions in SCI centres are 
based on sound research evidence, and potential barriers to good nutritional care in SCI 
centres.    
 
Objectives 
- To discuss centre based variation in the diagnostic criteria of malnutrition risk; 
diarrhoea and CDI and;  
 
- To report the development of a systematic review protocol on the use of 
probiotic in preventing AAD and CDI.  
 
Aim 3:  
To report three original studies (from a case study to a randomised trial) that explore 
how  nutritional interventions may influence clinical outcomes in SCI patients. 
 
Objectives 
- To discuss the impact of bariatric surgery (the first case in the UK) on a 
morbidly obese SCI patient, as a way to instigate body weight loss following the 
failure of other non-surgical interventions.    
 
- To report on the impact of nutritional supplements in SCI patients at risk of 
undernutrition, using a validated SCI-specific nutrition screening tool, the Spinal 
Nutrition Screening Tool, SNST.  
 
- To report the effectiveness of a commercial probiotic, Lactobacillus casei 
Shirota (LcS) in preventing AAD and CDI.  
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A total of seven reported studies, covering a range of methodologies (Table 1.1) were 
undertaken to demonstrate the vital role that dieticians play in the nutritional 
management of people with SCI.   
 
1.1.1 Outline of the thesis  
Within the thesis, section 1.2 provides brief details of the anatomy of the spinal cord 
and nature of SCI, which helps to understand the physical and psychological impact 
after SCI. This is followed by a brief description of SCI centres, their functions and the 
concept of multidisciplinary rehabilitation as the key to successful SCI rehabilitation.    
 
A critical review of the first study (Paper 5) will accompany in chapter one and it will 
discuss the variation of nutrition resources allocation across SCI centres and the impact 
of this variation. The prevalence, cause and consequence of malnutrition after SCI are 
discussed in section 1.4 covering both the acute and chronic phases of SCI.  This is 
followed by a review of current literature in general and SCI populations with particular 
focus on the unique metabolic changes in those with SCI in both the acute and chronic 
phase of SCI. The subsequent sections describe potential complications after SCI, the 
concept of gut microbiota and the use of probiotic in manipulating gut microbiota in 
preventing AAD / CDI.  
 
In chapter 2, attention will be given to the steps in identification of malnutrition risk and 
effect of malnutrition after SCI (section 2.1). The potential limiting factors obstructing 
optimal nutrition practice in SCI centres will be discussed. I also review the criteria for 
the the identification of overnutrition risk, choice of treatment and prevention strategies 
of obesity after SCI (Paper 4).  
 
SCI patients are susceptible to infections during their stay in SCI centre. Antibiotic 
associated diarrhoea could lead to additional healthcare costs and adverse consequence 
such as CDI. There is increasing evidence that probiotics when administered in 
adequate amounts confer a health benefit on the host, particularly in diarrhoea related to 
antibiotic used. To date, little evidence exists to support this concept in SCI patients. 
Therefore, the second study presented in chapter 2, provided unique insight into 
whether SCI centres use a standardised definition for malnutrition risk and AAD / CDI. 
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In addition the evidence on the use of probiotic in preventing AAD / CDI after SCI will 
be discussed. (Paper 6 and 7).  
 
In chapter 3, three original studies exploring how nutritional interventions may 
influence SCI patient’s clinical outcomes were critically reviewed.  The first study 
discussed the result on the use of nutritional supplements in SCI patients. The 
appropriate use of nutritional supplements was believed to be evidence-based in treating 
patients with an undernutrition risk. (Paper 1) The cause of obesity and its link with SCI 
must also be addressed (section 3.1). Although weight loss has been advocated as a 
primary strategy for the condition, to date, there is little guidance to support the 
nutritional management of morbid obese patients with SCI. Therefore, I discussed the 
impact on the first published bariatric surgery case report in SCI patients in the second 
study. (paper 2). This study recommends a carefully planned bariatric surgery with 
input from a multidisciplinary team could be an effective way to reduce the body weight 
of morbid obese SCI patients when they failed all non-surgical intervention. Finally, the 
effect on the use of probiotic (LCS) in preventing AAD in SCI patients was discussed in 
the third study. (paper 3) 
  
Finally, the findings of each of the linked seven studies and their implications for the 
nutritional management in SCI patients are discussed in chapter 4. Limitations of our 
studies are discussed as well as proposals for further areas of research in SCI patients. 
In summary, malnutrition after SCI is known to have a negative impact on clinical 
outcomes. The high burden to SCI patients and the healthcare system have recently been 
recognised, with a demand of timely specialist assessment and intervention. The studies 
undertaken and discussed in this thesis have contributed to the gap in the literature by 
identifying variations to the clinical management of SCI patients across SCI centres. As 
bed capacity in SCI centres is unlikely to change in the near future, this study proposes 
to improve early identification and management of malnutrition after SCI through 
implementation of nutrition screening tool and best practice recommendations. It is 
hoped that this will become embedded into routine clinical care and facilitate earlier 
focused interventions to improve outcomes in SCI patients with malnutrition.  
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1.1.2 Peer Reviewed Publications for Assessment 
Seven first authored papers are included for assessment. These papers clustered into 
four themes (section 1.1). These include 1) Complications related to malnutrition and its 
association to adverse clinical outcomes;  2: Current nutrition practice in SCI centres; 3: 
Role of nutrition intervention to treat / prevent nutrition related complications and; 4: 
Potential limiting factors for good nutritional care. They are summarised in Table 1.1 
and Figure 1.1, and are listed in chronological order beginning in 2013 through to 2015. 
 
1. Wong S, Graham A, Green D, Hirani S, Grimble G & Forbes A (2013) Nutritional 
supplement use in patients admitted to spinal cord injury centre, J Spinal Cord Med 
36, 645-651.  
 
2. Wong S, Forbes A, Barnes T, Coggrave M, Pounds-Cornish E, Appleton S & Belci 
M (2013) Morbid obesity after spinal cord injury: an ailment not to be treated? Eur 
J Clin Nutr 67, 998-999.  
 
3. Wong S, Jamous A, O’Driscoll J, Sekhar R, Weldon M, Yau CY, Hirani S, 
Grimble G & Forbes A (2014) A Lactobacillus casei Shirota probiotic drink 
reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a 
randomised controlled trial. Br J Nutr 111, 672-678.  
 
4. Wong S, van Middendorp J, Belci M, van Nes I, Roels E, Smith E, Hirani S, 
Forbes A (2015) Knowledge, attitudes and practices of medical staff towards 
obesity management in patients with spinal cord injuries: an international survey.  
Spinal Cord 53, 24-31.  
 
5. Wong S, Graham A, Hirani SP, Charlton D, Colawood S, McKeown E, Taylor C & 
Saif M (2015) Review of dietetic service provision and activity in spinal cord injury 
centres: a multicentre survey in the UK and Republic of Ireland. Spinal Cord. 53, 
855-859. 
 
6. Wong S, Saif M, O’Driscoll J, Kumar N, Smith E, Roels E, van Nes I, Faber W, 
McKwown E, Hirani SP, Jamous A (2015) Survey on the use of probiotics in 
preventing antibiotic associated diarrhoea and Clostridium difficile associated 
diarrhoea in spinal cord injuries centres. Int J Probiotics and Prebiotics 10, 85-90. 
 
7. Wong S, Jamous A, O’Driscoll J, Sekhar R, O’Driscoll S, Lewis S, McKeown E & 
Hirani SP (2015)  Effectiveness of probiotic in preventing antibiotic associated 
diarrhoea (AAD) and Clostridium difficile associated diarrhoea (CDAD) in patients 
with spinal cord injury: a protocol of systematic review of randomised controlled 
trial. Syst Rev 24, 170. Doi: 10.1186/s13643-015-0159-3. 
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Table 1.1: Summary of papers for assessment 
 
Aim Author  Objective   Research   Setting sample size       data    Main results   Conclusion  
Year      approach  subject          collected  
Journal 
 
3 1.Wong et al  To (1) assess food intake ; prospective  single centre   n=73           use of supplement  19.1% receive ONS  Use of supplements in common 
2013  2) establish prevalence of  observational SCI patient            vitamins and mineral 46.5% receive VMS  in SCI patient, particular in older  
J Spinal Cord Med dietary supplement use;  study (survey)             (VMS) and oral  patient at under-nutrition risk adults and those with poor nutritional 
   3) identify characteristics of                nutritional supplement were found to consume more   status. 
   supplement user in SCI patients                          (ONS)  ONS than the lower risk (p=0.05) 
 
1, 2 2. Wong et al To report the first UK   case-report  SCI patient     n=1          weight, body-mass-  Clinical significant weight loss  The provision of bariatric surgery 
2013  morbidly obese SCI patient              index (BMI), mid-arm (32.4 kg) after the surgery  should be consider as an option 
Eur J Clin Nutr who has undergone bariatric               circumference (MAC), There were improvement in for morbid obese SCI patient if all non- 
   surgery                triceps-skinfold thickness  BMI, waist circumference, surgical interventions have been tried. 
                   (TSF) and lipid profile.  TSF, MAC, lipid profile  
             and functional improvement. 
  
 3 3.Wong et al To 1) assess the efficacy of  Open-labelled Single centre    n=164          occurrence of diarrhoea Intervention (LcS) group had LcS could reduce incidence of AAD   
2014  Lactobacillus casei Shirota randomised   SCI patients     n=76 receive    defined as 2 x type 5 or    significant lower incidence of   in hospitalised SCI patients. 
Br J Nutr  (LcS) in preventing diarrhoea controlled trial      LcS          above loose stool (Bristol AAD (17.1 v 54.9%, p=0.022) a placebo-controlled RCT is needed 
   associated with antibiotic         n=82 receive    stool scale).   Undernutrition and PPI use  to confirm this apparent benefit  
   (AAD) and C. diff (CDAD)        control           undernutrition risk using  are associated with AAD. 
   2) determine if undernutrition       (routine) care     SNST score ≥11   poor appetite (OR 5.04) and 
   risk and proton pump                           no LcS (OR 8.46) were found 
   Inhibitor (PPI) use is risk         as independent risk factors for 
   factor for AAD/CDAD         AAD. 
 
1,2  4.Wong et al To 1) examine the opinions of Prospective   multicentre       n=18         37-item questionnaire little (2.8%) medical staff Appropriate training should be  
2015  medical staff working in SCI  observational n=18     SCI centres       to identify current   receives training in obesity  considered for all medical staff 
Spinal Cord  centres (SCICs); 2) evaluate  study (survey)  SCI centres           knowledge, attitude and management.  Development of SCI specific 
   their knowledge, attitudes and               practices of medical 61% of doctor did not consider weight management guideline 
   Practices towards obesity               staff.   BMI is appropriate after SCI  should be considered. 
   Prevention and management        Respondents also indicated 
   3) report number of beds and        the need for weight management 
   dietitians available at SCICs        guideline. 
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Theme Author  Objective   Research   Setting sample size       data    Main results   Conclusion  
Year      approach  subject          collected  
Journal 
 
1 5.Wong et al To 1) establish and compare Prospective   multicentre   n=12        total SCI beds and whole 8/12 SCI centres responded        Resources allocated to nutritional 
2015  how much time dietitians spend observational  n=12    SCI centre        time equivalent (WTE) 6/8 SCI centres used validated care appear to be varied and limited 
Spinal Cord  in direct and indirect contact  study (survey) SCI centres         dietitians, medical staff, nutrition screening tool.  in SCICs. 
   with patients; 2) document            nurses and other allied staffing level varied and below No recommendation currently made 
   current nutritional screening            health staff.  recommended level.   for dietitians working in SCICs 
   practice              dietitians were ask to fill in Dietitians spend 39.1% time in  further workforce planning for  
                 A week work sampling tool  direct patient activities  dietitian should be considered. 
 
 
 
2 6.Wong et al To 1) determine if SCIC stock Prospective   multicentre    n=12           centre’s demographic 5/9 SCIC stoked probiotic There is a need to use a standardised 
2015  probiotics; 2) determine whether observational n=9            number of bed days 5 probiotic were identified definition of diarrhoea when  
Int J Prob & Preb the use of those probiotic was  study (survey) SCI centre            use of probiotics   LcS (44.4%), L. casei DN-114001  conducting AAD/CDAD research 
   Evidence-based; 3) document   4 in the UK            indication of probiotics (22.2%), L. acidophilus (22.2) and   
   C. diff infection (CDI) practice   1 in the Republic of           incidence of CDI  Ecologic Pro-AD (11.1%) were  
        Ireland            CDI practice  choice for AAD prevention. 
        1 in Belgium           definition of diarrhoea Mean CDI was 0.307 per 10,000 
        3 in the Netherlands    patients-days. (range 0 to 1.08) 
             Definition of diarrhoea were varied 
             among SCICs 
 
2 7.Wong et al To report a systematic review systematic review N/A       N/A           Cochrane library;  N/A    This systematic review will provide 
2015  protocol in assessing the  protocol               Centre for Reviews      information on probiotic therapy for  
Sys Rev  effectiveness of probiotic                and Dissemination;      and CDAD in SCI population. 
in preventing and treating               CINAHL; PsycINFO      Preliminary search identified only 2  
   AAD and CDAD in SCI                 Embase; Medline;      studies reported using probiotic 
   Patients.                  AMED; International      to prevent / treating AAD / CDAD. 
                    Clinical Trials Registry     (Paper 3) 
 
Aim 1: To review and understand the variations in nutritional management in SCI centres from the perspective of staff and SCI patients. 
Aim 2: To evaluate whether currently implemented nutrition interventions in SCI centres are based on sound research evidence, and potential barriers to good nutritional care in SCI centres.    
Aim 3: To report three original studies (from a case study to a randomised trial) that explore how  nutritional interventions may influence clinical outcomes in SCI patients. 
 
ONS: oral nutritional supplement; VMS: vitamin and mineral supplements; SCI: spinal cord injury; AAD: antibiotic associated diarrhoea; CDAD: Clostridium difficile associated diarrhoea; CDI: Clostridium difficile 
infection. 
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Malnutrition is common after SCI 
How could we identify patient at malnutrition risk? 
Section 2.1; Paper 5 
What are the complications relate to 
malnutrition?  
Section2.2; Paper 2, 3 
Would malnutrition lead to poorer 
clinical outcomes? 
Section 2.3; Paper 2, 3  
 
Would appropriate nutrition 
intervention improve clinical 
outcomes? 
 
e.g. weight loss, functional 
outcome, reduce risk of AAD 
Chapter 3; Paper 2, Paper 3 
Undernutrition Overnutrition 
 
Nutrition intervention 
 
Obesity / Morbid obesity 
Section 3.1; Paper 2  
 
Role of Dietitian in managing 
morbid obesity? 
Bariatric surgery  
Paper 2   
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Increase risk of AAD / CDAD 
Section 3.3; Paper 3 
 
Do we use of ONS / VMS in 
patients at under-nutrition risk? 
Section 3.2; Paper 1  
Would er probiotics to 
prevent AAD in SCI patients?  
Section 1.4; Paper 3, 6 
What are the limiting factors for 
effective use of nutrition 
supplements? 
Different diagnostic criteria for 
diarrhoea, probiotic stocks varied, 
limited evidence in SCI population 
Section 2.4; Paper 6, 7 
 W
h
at
 a
re
 t
h
e 
p
o
te
n
ti
al
 li
m
it
in
g 
fa
ct
o
rs
 f
o
r 
go
o
d
 n
u
tr
it
io
n
al
 c
ar
e?
 
Su
b
o
p
ti
m
al
 r
es
o
u
rc
es
 /
 a
tt
en
ti
o
n
 f
o
r 
n
u
tr
it
io
n
 in
 S
C
I c
en
tr
e 
 
Se
ct
io
n
 1
.3
.3
; P
ap
er
 5
 
Future work (Section 4.1) 
Systematic review on probiotic in 
preventing AAD / CDAD (Paper 6) 
Multicentre RCT  
Weight management guideline 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 1.1: Summary of all papers  for assessment 
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1.2 Spinal Cord Injury 
SCI occurs when the spinal cord (SC) is damaged, usually due to fracture of the 
vertebral column, which normally encases and protects the SC. (Figure 1.2) However, 
SCI may be present even without osteoligamentous injury, one example is SCI without 
radiographic abnormality (SCIWORA), (Consortium of Spinal Cord Medicine, 2004) 
The paediatric population is predisposed to SCIWORA because of the laxity of cervical 
spine ligaments. Importantly, SCI causes all of the systems of the body to function 
differently to those of a non-paralysed person, and in addition leads to other issues, such 
as loss of sensation or movement and spasm. The level of SCI may affect organ 
function. For example, cardiovascular, respiratory, bladder and bowels, metabolic and 
psychological, and sexual functions.   
The most common mechanism of SCI is a sudden, unexpected, impact or deceleration 
on the SC, which accounts for approximately 73 % of all SCI cause. The rest of the SCI 
are non-traumatic SCI (27 %). (Spinal Injury Association, 2009). Road traffic accidents 
(RTA) are the most common cause of traumatic SCI, which accounts for 36 % of all 
causes of SCI, followed by domestic and industrial accidents (37 %), sports and 
recreational accidents (21 %) and finally self-harm and criminal assault (6.5 %). (Spinal 
Injury Association, 2009)    
 
Non-traumatic SCI is any damage to the SC that has not been caused by a major trauma 
such as infection (inflammatory or infectious), loss of blood supply (vascular), 
compression (neoplastic) or slow degeneration of spinal bones, such as osteoarthritis 
(degenerative). Non-traumatic SCI contributes to approximately one third of all SCI 
causes and there is a growing population of admissions for rehabilitation (Ho et al., 
2007).  
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Figure 1.2: The human spine  
The cervical spine extends from C1 to C7, the thoracic spine from T1 to T12, the lumbar spine 
from L1 to L5, followed by the sacrum and coccyx.  
(Copyright 1962 & 1992. Icon Learning Systems, LLC, a subsidiary of MediMedia USA Inc. 
Reprinted with permission from ICON Learning Systems, LLC, illustrated by Frank H. Netter, 
MD) 
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The first published report of SCI was translated by James Henry Breasted in 1930. This 
document, known as the Edwin Smith papyrus, contained details of an unknown 
Egyptian physician accurately describing the clinical features of traumatic tetraplegia 
(quadriplegia). The documents, dating to 2500BC, describe 48 traumatic cases, six of 
which involved the cervical injury. The Edwin Smith papyrus described that the patient 
would have priapism (erection), and incontinence of urine and semen.  It also revealed 
an awareness of the awful prognosis of SCI with chilling advice: “an ailment not to be 
treated”. (Hughes, 1988) This Egyptian physician suggested that the two SCI cases were 
not to be treated at all, probably due to their poor prognosis. Obviously, this physician 
had sufficient knowledge of anatomy and the surgical skills of his days; however, he 
may have also been aware that his resources were limited, preventing SCI patients to 
recover and return to their normal life.  
 
More recently, during the First World War, 90% of patients who suffered a SCI died 
within a year of being wounded, and approximately only 1% survived for more than 20 
years. This survival rate after SCI has greatly improved since the introduction of 
modern multidisciplinary and comprehensive SCI management, which was first 
promoted by Sir Ludwig Guttmann (Guttmann, 1970). The model SCI Centre system 
was described by John Young (1919-1990) such that it “must be able to meet the needs 
of a person with SCI by competently treating the direct injury as well as all organ 
systems affected (of which there are many), the functional deficits that result, by 
providing training and equipment, the psychological adjustments that must be made, the 
vocational pursuits that must be changed, and provide long term specialised care”. 
(Silver, 2003) In addition, he also outlined the core components of such a system which 
must include emergency medical services, emergency trauma centre, acute hospital 
care, acute rehabilitation care and on-going rehabilitation treatment.   
 
1.2.1 Terminology and classification 
SCI is an injury to the SC from traumatic or non-traumatic causes. SCI are classified 
according to the level of the corresponding vertebra (cervical spine, thoracic spine, 
lumbar spine or sacral spine) at which the injury to the SC occurs. For example, a break 
in the fourth segment of cervical spine is called a C4 injury. After SCI, depending on 
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the level and severity, an individual will experience complete or partial loss of sensory 
(sensation) or motor (movement) functions below the injury. 
 
Damage to neural elements within the cervical area result in tetraplegia (quadriplegia), 
and depending on the specific location and severity of injury, varying degrees of motor 
and sensory impairment will occur in the arms, trunk, legs, bowel, and bladder. For 
example, injuries at C1/2/3 levels will often result in loss or reduced diaphragm 
function and the patient will be very likely to need life-long ventilation; injury at C4 
level will result in significant loss of function at the biceps and shoulders; at C5 level 
will result a complete loss of function at the wrists and hands; at C6 level will result a 
limited wrist control and complete loss of hand function; C7 and T1 level will result in 
lack of dexterity in the hands and fingers. (Fig 1.4 and Fig. 1.5) 
 
Damage to the thoracic, lumbar, or sacral segments results in paraplegia. Paraplegics 
will experience a variable degree of motor and sensory function loss in the trunk, legs, 
bowel and bladder. The arms are spared in paraplegia.  
 
In 1982, the American Spinal Injury Association (ASIA) published its first edition of 
the Standards for Neurological Classification of Spinal Injured Patients. (ASIA, 1992) 
These standards arose from a need for more precise definition of neurological levels and 
the extent of incomplete injuries. The ASIA standards focused on 10 key muscles and 
10 key sensory points to be tested during a neurological assessment. The ten key 
muscles, five in the upper limb and five in the lower limb, are tested while the patient is 
lying in the supine position and require minimal movement of the spinal column. 
Likewise, key sensory points are selected to represent each sensory dermatome from C2 
through to S4-S5. 
 
The muscles of both extremities are very important for classification of injury level after 
SCI. An accurate evaluation of voluntary motor function is very important because it 
will provide a starting point for the therapeutic programme and it is also a reflection of 
neurological level of injury. A standardised form to be used as a flow chart for 
classifying SCI was also developed by ASIA as shown in Fig. 1.4 and Fig. 1.5. An 
AISA Impairment Scale (AIS): A indicates a complete SCI; there is no motor or sensory 
function preserved in the sacral segments S4-5. AIS B, C and D are incomplete SCI.  
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AIS B only preserved sensation below the neurological level, including sacral segments 
S4-5. AIS C preserved motor function below the neurological level and the majority of 
muscles having a grade less than 3 out of 5. AIS: D preserved motor function below the 
neurological level and the majority of key muscles below the level having a grade 3 or 
greater and AIS E indicates that motor and sensory function is normal.(Fig 1.5) These 
standards were endorsed by the International Medical Society of Paraplegia (now the 
International Spinal Cord Society (ISCOS), www.iscos.org.uk) creating the 
International Standards for Neurological and Functional Classification of Spinal Cord 
Injury. (ASIA, 2015)  
 
Sacral-sparing is evidence of the physiological continuity of SC long tract fibres (with 
the sacral fibres located more at the periphery of the cord). This translates into a simple 
definition of “complete SCI” if they do not have motor and sensory function in the anal 
and perineal region representing the lowest sacral cord at S4 and S5 (as this is the last 
part of the SC). Indication of the presence of sacral fibres is of significance in defining 
the completeness of the injury and the potential for some motor recovery. (ASIA, 2015)
  
(Figure 1.3 and Figure1.4). 
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Figure 1.3: International standard for neurological classification of spinal cord injury. Reproduced with permission of the American Spinal Cord 
Injury Association. 
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Figure 1.4: ASIA impairment scale grading: International standards for neurological classification of spinal cord injury. Reproduced with permission of the 
American Spinal Injury Association 
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1.2.2 Physical and psychological effect after SCI 
The level and severity of injury to neural tissue determines the symptoms produced by 
SCI. There are primary and secondary effects after SCI. The primary effects include 
paralysis (section 1.5), spasm and reduced or loss of sensation or movement. The level 
of SCI may affect organ function. Due to prolonged decreased mobility, patients with 
chronic SCI can also develop a variety of secondary effects (complications) on skin 
(pressure ulcers), respiratory, circulatory, gastrointestinal, urinary, metabolic and bone. 
Many patients are depressed and disinterested in eating after SCI. Studies reported 20 – 
62% of patient will suffer from depression after acute SCI. (Judd et al, 1991)  Some 
may be confused or have a decreased level of consciousness especially during acute the 
phase of SCI. (Consortium for Spinal Cord Medicine, 2008) 
In addition, tetraplegic with a particularly high level of injury may also lose the ability 
to breathe for themselves; therefore, they may have to rely on mechanical ventilation. 
Table 1.2 & Table 1.3 summarise the primary and secondary physical effects after SCI 
and Fig 1.3 summarises the physical and physiological consequences of SCI. 
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Table 1.2: The primary effects and change in organ functions after spinal cord injury 
Primary effects    Effects       Treatment options 
Paralysis      Unable / difficulty to move the body in space 
 
Spasticity     Development of contracture     Botulinum toxin 
     Muscle shortening and reduction of range of motion  Use of baclofen, tizanidine and dantrolene  
     Difficulty in positioning     Intrathecal baclofen to help those who do not respond to oral  
medication 
Disruption of sensation   Discoordination of body movement 
     Vulnerable to trauma 
     Impaired body awareness 
 
Decreased range of motion   Deformities 
     Limited functional capacity 
Organ functions 
Respiratory     Reduction in inspiratory & expiratory ability 
Increased energy of breathing 
Inability to breathe without mechanical ventilation (high cervical SCI);  
Paralysis / weakness of diaphragm 
Diminished tidal volume and vital capacity 
 
Gastrointestinal     Decreased oesophageal motility    Prokinetics, help stomach to empty faster 
     Faecal impaction      laxatives 
      
Bowel and bladder continence  Urinary retention       Urodynamics to examine the bladder function to inform best treatment  
Loss of voluntary bowel and bladder control   approaches 
     Bladder infection and bowel obstruction 
      
Genital function    Disruption of sexual functions 
     Infertility in men 
 
Cardiovascular function   Bradycardia (slowing heart rate) 
     Hypotension 
     Orthostatic hypotension 
 
Thermo regulation    Hypothermia 
     Absence of shivering 
     Loss of sweating in response to a rise in body temperature   
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Table 1.3: The secondary effects after spinal cord injury, their complications and available treatment options. 
Secondary effects    Complications     Treatment options 
 
Pressure ulcers    Osteomyelitis     Infection being treated by antibiotics 
     Sepsis      Conservative / Surgical procedure to enhance wound healing 
     Death 
 
Respiratory complications   Atelectasis     Infection being treated by antibiotics 
     Pneumonia 
 
Decreased range of motion   Cosmetic problems     Botulinum toxin  
     Increase vulnerability to pressure ulcers  physiotherapy and occupational therapy 
 
Osteoporosis    Increase vulnerability to fracture   vitamin D, calcium  supplementation  
 
Gastrointestinal complications  Stress gastric / duodenal ulcers   proton pump inhibitor / H2 blocker 
     Paralytic ileus     Parenteral nutrition 
     Gastric dilatation     laxatives 
     Faecal impaction     surgical procedure (e.g. colostomy) in severe case 
     Bowel obstruction 
 
Urinary tract complications   Bladder infection     infection being treated by antibiotics 
     Urinary reflux     urodynamic to examine bladder function to inform best treatment option 
     Kidney & bladder stones    Electro-hydraulic lithotripsy 
     Hydronephrosis & pyelonephrosis 
     Kidney failure 
     Septicaemia      
 
Metabolic / nutrition related   Osteoporosis      vitamin D supplementation 
complications    Change in body composition    Dietetic assessment / intervention 
     Change in nutritional requirements   Dietetic assessment / intervention 
     Increase risk of developing metabolic syndrome 
 
30 
1.2.3 Epidemiology and financial impact  
The annual incidence of SCIs throughout the world is 15 to 40 cases per million 
(Sekhon & Fehlings, 2001). It is estimated that there are around 500 to 700 cases of SCI 
each year in the UK (Spinal Injury Association, 2009), and based on a total UK 
population of 62.3 million, this is equivalent to 8 – 11 cases per million (Office for 
National Statistics, 2010). In 2009, it is estimated that there are currently 40,000 people 
living with SCI in the UK. (Spinal Injury Association, 2009)   
 
The cost of medical care for people with a SCI continues beyond the first year after 
injury, and once the condition of individuals with a SCI has stabilised, they require the 
services of health-care practitioners on a continuing basis. Some people undergo 
recurring hospitalisation for a variety of reasons associated with their SCI, ranging from 
chronic issues that are directly linked to the injury or secondary complications, such as 
pressure ulcers, pneumonia, muscular/joint problems, and obesity. Individuals with a 
chronic SCI require a much higher level of medical maintenance and follow up than the 
able bodied population because their medical symptoms are often masked by the lack of 
sensation following a SCI. There is limited analysis on the money spent in the UK on 
SCI patients. Berkowitz and colleagues (Berkowitz et al, 1998) estimated that the cost 
for continuing medical care for a person with SCI was $9,000AUD (£5,769) a year, 
with higher costs associated with more severe injuries. In addition, older adults incur a 
higher cost than their younger counterparts, and women incur slightly higher costs than 
men.  
 
Using an estimate incidence of 8 to 12 cases per million per year, and the total 40,000 
SCI patients living in the UK currently, the initial costs of treatment after SCI will be 
£86 to £130 million with a further £2.3 billion being spent on continuing care per year. 
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1.3 Spinal cord injury centre 
In 1941 Ludwig Guttmann was asked by the Medical Research Council to report on the 
current situation regarding the treatment and rehabilitation of patients who had suffered 
a SCI. The result of this report caught the attention of Colonel George Riddoch, a 
neurologist and Chair of the Peripheral Nerve Committee of the Medical Research 
Council of England. Subsequently, Ludwig Guttmann was put in charge of establishing 
a new spinal unit under the supervision of the Ministry of Pensions, and chose Stoke 
Mandeville Hospital in Aylesbury. This was as its facilities were all at ground level with 
wide corridors, therefore accessible for wheelchairs. In 1944 the National Spinal 
Injuries Centre (NSIC) at Stoke Mandeville Hospital was opened. 
 
Currently, the UK’s SCI centres form a highly specialised NHS rehabilitation service, 
which supports individuals with SCIs from their initial injury and throughout their life.  
Each centre has its own out-patient department providing lifelong follow up for their 
patients.  An early Canadian study compared outcomes for SCI patients before and after 
their introduction of specialist SCI centres (Tator et al, 1995). The authors reported 
reduced mortality and length of hospital stay (LOS) for all SCI patients when managed 
in a SCI centre. More recently, an Australian study (New et al, 2011) looked at the 
impact on patients admitted to different types of centres and identified a lack of uniform 
standards affecting outcomes. A systematic review of the impact of acute care in SCI 
centres with regards to LOS, complications and mortality (Parent et al, 2011) identified 
15 studies with reported outcomes for a cohort of at least 10 patients. The authors 
reported patients who were transferred to a SCI centre promptly after injury, tends to 
had a shorter LOS, fewer complications and greater neurological recovery, supported by 
staff with clinical expertise. Although the evidence generated was weak, the authors 
recommended to facilitate early transfer to SCI centre and to engage multi-disciplinary 
staff to reduce the severity and rate of complications and overall mortality.   
 
A Cochrane review of SCI centres for acute management (Jones & Bagnall, 2004) noted 
that the majority of complications of SCI can occur in the first 24 hours. However, they 
found insufficient evidence to support conclusions concerning the benefits or 
disadvantages of immediate referral versus late transfer to SCI centres, suggesting the 
need for a well-designed prospective study to address this question. Aito (2003) noted 
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that pressure ulcers and respiratory complications were much more common among 
patients who were treated in non-specialised units or who had experienced delays in 
their transfer to a SCI centre. Aung and el Masry (1997) showed that patients admitted 
to an SCI centre within one week of a SCI suffered a lower rate of complications 
compared to those admitted later. Similarly, DeVivo et al. (1990) found statistically 
significant reductions in acute care, and in the total length of stay, coupled with a highly 
significant reduction in pressure ulcers among patients admitted to SCI centres within 
one day of a SCI, compared to an otherwise comparable group of patients admitted to a 
SCI centre for rehabilitation only supporting the concept of SCI centres and potential 
benefit of transferring to SCI centre at early stage of their SCI.  
 
Across the UK and Ireland, there are 12 SCI centres, with eleven in the UK, eight in 
England, one in Scotland, one in Wales and one in Northern Ireland, providing a total of 
458 in-patients beds for the rehabilitation of people who have a SCI. The total number 
of beds in these units is under pressure and unable to meet the demands. As referral 
numbers exceed the capacity, this leads to significant delays in transfer of patients to 
SCI centre leading to an increased report of complications. Whilst SCI centre capacity 
are unlikely to change, ensuring a consistent approach to nutritional care would improve 
clinical outcomes and improve a patient’s quality of care. This study sought to 
understand the variation in nutrition practice across UK SCI centres.  
 
1.3.1 The National Spinal Injuries Centre at Stoke Mandeville Hospital 
The NSIC at Stoke Mandeville Hospital is the oldest and one of the largest SCI centres 
in the world, providing a total of 115 beds for people with a SCI; 62 of these are for 
active rehabilitation, and there is a dedicated young person’s rehabilitation unit 
consisting of 9 beds. The remaining beds are for acute admissions, people who are 
medically unstable, and for secondary elective admissions.  
 
1.3.2 Dietetic services within SCI Centres 
Although dieticians have been widely accepted as core multidisciplinary team members 
across other medical specialties, such as intensive care (Intensive Care Society, 2015), 
unfortunately dietetic therapy and resources in SCI centres is widely under-utilised. 
(Wong et al, 2012c) Indeed, low staffing level issues were also highlighted in recent 
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international SCICs survey. (New et al, 2013)  Therefore, we conducted an update 
survey of service provision at SCI centres across both the UK and the Republic of 
Ireland in 2015. Paper 5 will be used to support this section. 
 
Paper 5: Wong S et al. (2015) Review of dietetic service provision and activity 
in spinal cord injury centres: a multicenter survey in the UK and Republic of 
Ireland. Spinal Cord. 53: 855-859. 
 
In order to understand the potential impact on the variations in nutritional resources 
allocation and management in SCI centres, we surveyed all twelve SCICs surveyed (11 
in the United Kingdom and 1 in the Republic of Ireland) again in 2014. Eight (66.7%) 
centres respondents (7 in the UK and 1 in the Republic of Ireland) completed and 
returned the questionnaire. The centres represented 390 of 531 (73.4%) UK and Ireland 
SCI beds (1 SCIC in the Republic of Ireland (n=36), 7 SCICs in the United Kingdom 
(n=354). There is no current guidance on nutrition screening after SCI, although all 
SCICs reported that they used a nutritional screening tool, only six of eight SCICs 
(75%) used a validated nutrition screening tool (n=3: Malnutrition Universal Screening 
Tool; n=3: SNST and the remainder (n=2) used a local non-validated tool.  
 
Variations were observed across the UK SCI centre’s nutrition practice since our first 
report in 2008 (Wong et al, 2012c). Six of eight (75%) SCICs reported they aim to 
complete nutritional screening within 24 hours of admission and two of eight SCICs 
(25%) aimed to complete nutritional screening within 48 hours. We found one WTE 
dietician covering between 60-160 patients (national average of 99.5 patients) and six 
out of the eight centres surveyed were below the clinical recommendations (Wong et al., 
2012c; Paper 5). 
 
Insufficient resources may impact greatly on the nutritional knowledge of patients and 
staff at these centres and is likely to contribute to the under-recognition and under-
treatment of malnutrition. Only three of eight (37.5%) SCICs meet the recommended 
dietitian to bed ratio 1:60 set by the SCI dietitians group of the British Dietetic 
Association (Wong et al, 2012c). Additionally, dietitians in five of eight (62.5%) SCICs 
still report covering more than 100 patients per WTE. A study by Windle (2008) found 
that the allocation for dietitians in the adult intensive care unit was also under resourced. 
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The variation in staff levels could be due to each SCIC having its own unique needs and 
challenges and therefore comparisons do have limitations (especially over a small 
sample of centres). However the impact remains; recent literature suggests malnutrition, 
including both under- and over-nutrition (obesity) is common in patients with SCI and it 
is associated with poorer clinical outcomes and increased healthcare costs. (Wong et al, 
2013)  Our previous study (Wong et al, 2012d) from SCI centres reported staff agreed 
that poor oral intake or prolonged intubation were criteria for artificial nutrition support. 
Our recent study (Wong et al, 2012a), reported undernutrition is common in SCI 
patients suggesting that clinical guidance may not be routinely applied in SCI centres.  
 
At the present time, no formal recommendation has been set by the specialist 
commissioners for an optimal staffing level for dietitians. (NHS England, 2013) Our 
study found the provision of dietitians did not significantly improve in the last five 
years (Table 1.4) that the number of staff in different SCICs still varied considerably 
(34 to 160 beds per WTE dietitian) suggesting malnutrition may continue to be under-
detected and under-managed.   
 
There are some limitations of this study. Formal sample size calculation was not 
performed as the present study surveyed all SCI centres in the UK and Republic of 
Ireland, with a response rate of 66.7%. The response rate was comparable in literatures 
and we believed the study’s result could apply to UK SCI centres. However, the study 
did not address the non-response bias. Non-response bias is the bias that results when 
respondents differ in meaningful ways from non-respondents. Indeed, non-response is 
often a problem with mail surveys, where the response rate can be very low. It would be 
recommended in future study to assess non-response bias formally, and perhaps use 
more face to face resources to get more complete information. 
 
The present study’s questionnaire contains 37 items. It was based on previous published 
literatures. (Wong et al, 2011; Ward et al 2014) No data / responses were excluded from 
the analysis. Therefore, results derived from this sample of SCICs could be considered 
representative for the UK and the Republic of Ireland. Overall, in absence of empirical 
evidence, the result of this survey would provide an insight into current nutrition 
practice in the approach to nutritional management across SCI centres to identify 
consistent practices and areas requiring further development. 
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Table 1.4: Human resources allocation in participating spinal cord injury centres 
 
Staff category   Total WTE number of beds   2009 figures   p-value            National  
    Staff  per WTE staff  median; (range)                 recommendations  
      Median; range   
         
 
Consultants (n=7 SCICs) 18.0  18    (15.3-31)  15.0  (10.5-24.4)  0.153  15-20 
Other grades of medical staff 33.0  12    (6.2-46)  10.1  (7.5-20.0)  0.701  - 
Nurses  (n=6 SCICs) 325.7  1.3   (0.5-1.5)  1.3    (0.6-1.8)  0.748  2-3 
Dietitians (n=7 SCICs) 4.63  93.4 (34-160)  136   (30-387)  0.272  - 
Physiotherapists (n=7 SCICs) 65.49  5.9   (4-8)  5.6    (3.75-10.5)  0.848  5-7 
Occupation therapist (n=6 SCICs) 30.3  10.   (3.7-12.9)  10.5  (3-16.6)  0.617  6-8 
 
SCIC: spinal cord injury centre; WTE: whole time equivalent 
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1.4 Malnutrition after a SCI  
Studies from general populations have suggested that undernutrition is an important 
predictor of poor hospitalisation outcome, including increased length of hospital stay 
(Bauer et al., 2002;  Burr et al., 1993; Kagansky et al., 2005; Stratton et al., 2004; Van 
Nes et al., 2001; Wong et al, 2012c)
, 
 premature mortality (Van Nes et al., 2001; 
Sullivan et al., 1999; Studley et al., 1936; Kagansky et al., 2005; Desport et a.l, 1999; 
Wong et al, 2012c), post-operative complications (Hennessey et al., 2010), infections 
(Schneider et al., 2004), pressure ulcers (NICE, 2005), poor wound healing (NICE, 
2005), compromising of the immune system (Cruse et al., 2000),
 
and impaired muscle 
and respiratory function (Sullivan et al., 1999; Kagansky et al., 2005).  
 
The prevalence of undernutrition-risk in SCI patients is estimated to be high (44.3%) 
(Wong et al., 2012a). A higher prevalence of undernutrition risk was observed in 
patients with the following associated features: high cervical injury (60.7%), and the use 
of mechanical ventilation (56.3%) (Wong et al., 2012a). There are various possible 
causes of undernutrition; some may be present prior to hospital admission, whereas 
others develop during an inpatient stay (Persson et al., 2002). These include:  
 
 Inadequate food intake  
 Anorexia, dysphagia, vomiting, diarrhoea (undernutrition) 
 Poor availability of food due to social deprivation or variation in hospital 
practice  
 Reduced physical ability to eat due to arthritis, SCI 
 Reduced desire to eat due to chronic pain, neuropathic pain, depression 
or apathy may lead to loss of interest in food 
 Patients’ clinical state/disease process may increase metabolic rate and 
nutritional requirements 
 Unbalanced food intake 
 Defect in food digestion/absorption 
 Malabsorption issues, e.g. short bowel syndrome 
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1.4.1 Metabolic response in patients with acute SCI 
The early stages post-SCI, known as the acute phase could last up to 12 weeks after 
SCI. Malnutrition associated with this phase may be directly due to a suboptimal 
nutritional intake of calories and protein to meet the nutritional requirements due to 
hyper-metabolism post-injury, SCI related comorbidities, infection, and also 
dependence on ventilation (Kearns et al., 1992).  
 
The degree of hyper-metabolism may vary in severity depending on factors such as the 
degree of inflammation, age, and body composition
 
(Frankenfield et al., 1997). 
Metabolic changes are also present due to the initially elevated catabolic hormonal and 
cytokine responses, including increased blood levels of counter regulatory hormones 
(e.g. cortisol and catecholamines), increased blood and tissue levels of pro-
inflammatory cytokines (e.g. interleukin-1, interleukin-6 and tumour necrosis factor α), 
and peripheral-tissue resistance to endogenous anabolic hormones (e.g. insulin and 
insulin-like growth factor). 
 
Extensive multiple organ trauma, soft tissue injuries and fractures, may further increase 
the hyper-metabolic response. Evidence suggests that, in contrast to trauma and head 
injury, there is a reduction in energy expenditure during the acute SCI phase, but further 
evidence is needed to determine specific nutritional requirements post-injury (Buchholz 
& Pencharz, 2004).  
 
Similar to a state of starvation, a negative energy balance will result in the accelerated 
utilisation of fat and protein for energy due to the depletion of glycogen stores. This 
depletion may be caused by catabolism, nitrogen loss, and reduced protein synthesis, 
which when coupled with immobilisation and muscle atrophy, can lead to significant 
loss of lean muscle mass, up to 900g/day (Hadley, 2002). In addition, the administration 
of glucocorticosteriods after a SCI may increase the catabolism of protein. The loss of 
nitrogen in the urine, mainly due to muscle atrophy secondary to a SCI, increases with 
the severity of an injury, and a negative nitrogen balance is correlated with the level and 
extent of an injury, potentially lasting up to 2 months post-injury. This in turn may 
result in reduced gastrointestinal mucosal integrity, a compromised immune system, and 
an increased risk of infections.
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It is recommended to use indirect calorimetry to determine energy requirements for 
nutrition support in both acute and chronic SCI settings (Consortium for Spinal Cord 
Medicine, 2008; section 1.5.5). However, in absence of an indirect calorimeter, standard 
predictive energy equations should be adjusted to reflect caloric needs during the acute 
phase, to reduce risk of overfeeding. The American Dietetic Association guidelines 
recommend Harris-Benedict equation with an activity factor of 1.1 (for bedbound 
patients) and a stress factor of 1.2. The guidelines also recommend protein intake of 
2g/Kg body weight but these requirements may need to be adjusted with level of injury 
and AIS grade (ADA, 2009).  
 
In clinical practice, the timing to start feeding patients in the acute setting may be 
difficult to determine. In non-SCI traumas, early nutrition support (48-72 hours) is 
recommended to improve outcomes. (ADA, 2009) Complications of trauma, surgery 
and medications may increase risk of paralytic ileus. Patients with paralytic ileus, which 
generally occurs for the first 48-hours post-injury but may extend for a prolonged 
period, are generally kept nil by mouth for this period and oral or enteral nutrition 
initiated once signs of ileus are resolved. Parenteral nutrition (PN) may be indicated in 
patients with mechanical bowel obstruction or prolonged ileus until the bowel begins to 
recover and EN or oral diet is initiated. Both EN and PN have shown to reduce gastric 
ulceration in acute SCI and PN may also reduce the incidence of upper gastrointestinal 
bleeding in patients with poor oral intake. Table 1.5 summarises the impact on 
metabolism, nutritional status and nutrition requirements in acute and chronic phase of 
SCI. 
1.4.2 Psychological state after acute SCI 
The psychological consequences of having suffered a SCI should not be 
underestimated. Many patients are depressed and disinterested in eating and therefore 
may refuse to eat and or drink. Indeed, quality of life is often greatly reduced and 
secondary complications tend to increase morbidity and mortality. Studies reported 20 – 
62 % of patient will suffer from depression after acute SCI. (Judd et al, 1991)  Some 
may be confused or have a decreased level of consciousness especially during acute the 
phase of SCI. (Consortium for Spinal Cord Medicine, 2008) 
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Table 1.5 Impact on metabolism, nutritional status and nutritional requirements in acute and chronic phases of SCI  
Phase Acute  Chronic 
Impact on 
metabolism 
Depleted energy stores, utilisation of body fat and 
protein for energy, accelerated catabolic rate 
driven by inflammatory stress response, rapid 
nitrogen loss and reduced protein synthesis. 
Nutrient deficiencies.  
 
 Increased appetite and oral intake, reduced physical 
activity and immobilisation, muscle atrophy causing 
BMR reduction. Body composition changes: reduced 
fat free mass and increased fat mass 
Impact on 
nutritional 
status 
Loss of lean muscle mass, increased risk of 
infection, impaired wound healing, muscle atrophy, 
loss of gastrointestinal mucosal integrity, paralytic 
ileus, gastric ulcers.  
Increased risk of overweight and obesity, metabolic 
syndrome, hypercholesterolemia, increased risk of 
CVD, Diabetes type 2 and pressure ulcers.  
Nutritional 
requirements 
Energy Normal metabolism: 90-130% 
metabolic state 
Hypermetabolism: > 130% of 
metabolic state 
Tetraplegia: 22.7 Kcal/Kg BW 
Paraplegia: 27.9 Kcal / Kg BW.  
 
 Protein 2g / KG BW / day   0.8-1 g / KG BW 
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1.5 Complication after SCI 
1.5.1 Infections after SCI 
Infections such as chest, bladder and urinary tract infections are more common in 
patients with SCI. The frequency of pulmonary complications parallels the degree of 
respiratory impairment, increasing with progressively higher levels of SCI. Studies have 
reported that respiratory complications such as atelectasis, and pneumonia occur in 50 
to 67 % of patients with SCI at any level. (Fishburn et al, 1990) Due to the need for long 
term bladder catheterisation patients are particularly vulnerable to infections of the 
urinary tract or kidneys. It was reported that 80.4 % of SCI patients suffered from 
urinary tract infection (UTI) or bacteriuria. (Stover et al, 1999) 
 
1.5.2 Pressure ulcers 
Patients with SCI are susceptible to pressure ulcers (PU) and subsequent infection 
(Cruse et al, 2000a; Cruse et al, 2000b; Kaufman et al, 1985; Young et al, 1987). 
Developing PU is a significant risk for people with SCI (Consortium of Spinal Cord 
Medicine, 2008). A PU results when insufficient blood flow and decreased oxygen is 
delivered to specific pressure points in the body. This may be due to externally applied 
pressure for a prolonged period of time over bony prominences (Krause & Broderick, 
2004). After SCI, individual’s ability (sensation) to feel pain in a pressure area is 
impaired due to sensation loss and they are also unable to shift weight naturally due to 
mobility loss (Krause & Broderick, 2004). The level of SCI lesion is a significant factor 
in the development of PUs. An observational study carried out by Waters and 
colleagues (Waters et al, 2009) found that patients with complete SCI had more PU 
episodes per year than those with incomplete SCI, reinforcing the importance of sensory 
function as a risk factor for PU. When a PU is severe and not treated aggressively, it can 
lead to further disability, surgical interventions, amputations and fatal infections 
(Consortium of Spinal Cord Medicine, 2014).  
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PU account for nearly one fourth of the cost of care for individuals with chronic SCI.  In 
the US, the cost of care for PU is about 1.2 to 1.3 billion US dollar annually, with 
prevention costing one tenth of this. (Jones et al, 2003)
 
A recent study (Krause & 
Broderick, 2004) reported that nearly 90 % of PU is preventable and significant 
protective measures including life style, exercise and diet are essential. There is minimal 
research investigating the relationship between nutritional status and prevention and /or 
healing of pressure ulcers. Limited high quality studies do exist, however, that either 
quantify amounts of nutrients needed to prevent pressure ulcers or optimises the healing 
process once a pressure ulcer occurs in the SCI patients. (Chapman et al, 2011) Table 
1.6 summarises the nutritional consideration for those with a pressure ulcer. 
 
1.5.3 Swallowing difficulties 
SCI patients may also suffer from swallowing dysfunction that hinders their ability to 
tolerate oral food which may occur as a result of lying flat. Studies have reported that 16 
% of patients have dysphagia after SCI. (Seid et al, 2010) Ventilator support and 
tracheostomy may present physical barriers to eating and drinking (Wong et al, 2012a). 
Kirshblum and colleagues (Kirshblum et al, 1999) suggested that the presence of a 
tracheostomy appears to be a risk factor in causing dysphagia. If dysphagia remains 
undetected and untreated, aspiration pneumonia could result.   
 
1.5.4 Gastrointestinal complications 
Gastrointestinal factors such as dysphagia, ileus, nausea, vomiting, gastrointestinal 
bleeding, diarrhoea or constipation, early satiety and abdominal injuries may adversely 
affect patient’s nutritional status. (Consortium of Spinal Cord Medicine, 2008)  In 
addition, a compromised gut due to spinal shock could lead to gastric content aspiration 
and abdominal distension which could compromise dietary intake and ventilation. 
(Cheshire & Coats, 1966)  
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Table 1.6 Suggested supplementation for pressure wound healing versus Dietary recommended values (DRVs)  
 
Nutrient Energy 
(Kcal) 
Protein (g) Vit. A (µg) Vit. C (mg)  Zinc (mg) Iron (mg) 
DRV:  
EAR energy, RNI other 
nutrients 
Males 
 
 EAR: 2340 
-2550 kcal 
/ day  
53.3 – 55.5 700   40 9.5  
 
8.7 
 
Females 
1877 - 
1940 
45 – 46.5 600 40 7 8.7 – 14.8 
Supplementation 
suggestions  for specific 
deficiencies  with PU in 
SCI 
PU Stage 
I - II 
30-40 Kcal 
/ KG BW 
Or  
BMR x 
1.2* 
1.2 – 1.5 
g/Kg BW / 
day) 
3000 to 
15000 (up 
to 10 days)  
100 – 200 
 
220mg 
twice /day 
(or 50 mg 
elemental 
zinc) for 2-3 
weeks 
Supplementation 
should be 
provided as 
indicated to 
correct iron 
deficiency 
anaemia. 
PU stage 
III = IV 
30-40 Kcal 
/ KG BW 
Or 
BMR x 
1.5* 
1.5 – 2 
g/Kg BW / 
day) 
1000 – 2000 
*Harris-Benedict predictive energy equation times stress factor   
Abbreviations –  
DRV: Dietary Reference Values;  
EAR: Estimated Average Reference;  
RNI: Reference Nutrient Intake 
PU: pressure ulcer 
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1.5.5 Obesity 
Obesity is a common secondary complication of chronic SCI and is associated with 
adverse metabolic consequences. Recent studies suggested that up to 60% of patients 
with chronic SCI were overweight (body mass index: BMI >25 kg/m
2
) (Gupta et al, 
2006), and up to 30 % of patients are obese (BMI >30 kg/m
2
). A positive energy 
balance increases the risk of obesity. Total energy expenditure (TEE) is compromised 
due to a reduced basal metabolic rate (BMR) due to muscle atrophy (change in body 
composition), and a reduction in physical activity level (PAL).  In addition to those 
conditions common to the able-bodied population, a reduced function below the level 
predicted by the neurological lesion, pain, and compromised mobility are unique in 
obese patients with SCI. (Boninger et al, 1999) 
 
Total energy expenditure (TEE) 
TEE is composed of several different components including the body’s basal metabolic 
requirements (Basal Metabolic Rate: BMR), typically taken in a subject resting in a 
reclining position, after 8 hours of sleep and 12 hours of fasting; physical activity level 
(PAL),  diet induced thermogenesis (DIT) and non-exercise activity thermogenesis 
(NEAT).  
  TEE = BMR + PAL +DIT + NEAT 
 
BMR accounts for approximately 60 to 70 % of TEE. Resting energy expenditure 
(REE), the amount of energy required for a 24-hour period by the body during a non-
active period, is generally observed to be lower in people with SCI than those without 
(Buchholz et al, 2003; Liusuwan et al, 2007; Monroe et al, 1998), lower than predicted 
(Barco et al, 2002; Buchholz & Pencharz, 2004; Cox et al, 1985; Kearns et al, 1992; 
Supngen et al, 2003) and related to SCI level. (Mollinger et al, 1985)  
 
DIT is the increase in energy expenditure associated with digestion, absorption and 
storage of food, and accounts for approximately 10% of TEE. 
 
Activity thermogenesis is the thermogenesis that accompanies physical activities, 
therefore, can be divided into exercise and non-exercise activity thermogenesis (NEAT). 
After SCI, most individuals do not partake in purposeful sporting exercise, therefore, 
their NEAT could be as low as zero; for those who do exercise / train regularly, 
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exercise-related energy expenditure is generally 10% of the TEE. NEAT or the “energy 
expenditure of spontaneous physical activity” encompasses the combined energy cost of 
physical activities of daily living, spontaneous muscle contraction, fidgeting and 
maintaining posture when not recumbent and accounts for the remainder of the TEE.  
 
TEE can be predicted or measured. At a clinical level, BMR is often expressed as a 
function of body weight using predictive equations such as the Schofiled equation 
(Schofield, 1985) and Harris & Benedict’s equation (Harris & Benedict, 1919), the 
majority of them are validated in able-bodied subjects.  
 
When used in the SCI population, such predictive equations overestimate measured 
requirements by 5 to 32 % (Barco et al, 2002; Buccholz & Pencharz, 2004; Cox et al, 
1985; Jeon et al, 2003; Mollinger et al, 1985; Shedlock & Laventure, 1990; Shizgal et 
al, 1986; Spungen et al, 2003), most markedly in tetraplegic patients (Cox et al, 1985; 
Mollinger et al, 1985). Similarly, measured BMR has been found to be 14 to 27 % 
lower in people with chronic SCI than in able – bodied controls (Buccholz & Pencharz, 
2004; Jeon et al, 2003; Monroe et al, 1998). It is recognised that not all clinical 
rehabilitation centres will have access to an indirect calorimeter to measure BMR. 
(Consortium for Spinal Cord Medicine, 2008) To avoid over- and under- feeding SCI 
patients during an acute phase and overnutrition in a chronic phase of injury, 
development of a new equation to predict requirements in SCI is needed. In addition, 
this new equation should be validated and prospectively tested in a large sample of men 
and women with complete and incomplete tetraplegia and paraplegia. In absence of 
disease specific predictive equations, the use of general equations could lead to obesity. 
Practitioner working in SCI centre should be cautious when using predictive equations.  
 
Two possible mechanisms to explain the reduced BMR in patient with chronic SCI has 
been proposed:  1.) Change in body composition: reduced fat free mass (FFM) and; 2.) 
Altered sympathetic nervous system activity.  
 
Reduced fat free mass (FFM) 
Body composition changes after SCI in response to reduced physical activity, 
immobilisation or disease. This causes a reduction in metabolically active tissue (FFM) 
and increase in adiposity levels and as a consequence, energy balance becomes more 
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difficult to maintain. In a cross sectional study of 133 SCI males (Spungen et al, 2003), 
it was found that body composition changes were exaggerated with advancing age and 
resulted in increased body fat and loss of FFM (muscle). The result was significantly 
greater than those of an ethnicity-matched able-bodied cohort.  
 
BMR is predominantly determined by FFM which accounts for over 70 % of the 
variation in BMR. This is due to the numerous high energy processes which occur in 
organs and muscles, including ion pumps, synthesis and degradation of cell constituents 
and various biochemical cycles. Patients with chronic SCI have a reduced FFM (Jeon et 
al, 2003). Therefore, a decrease in FFM may result in a decrease in BMR. 
 
Altered sympathetic nervous system activity 
Sympathetic activity is dependent on the neurological level of the lesion; high level 
SCI, is associated with markedly decreased sympathetic activity (Schmid et al, 2000). 
Because of this, it has been questioned whether the BMR should be adjusted for body 
composition or sympathetic nervous system activity when comparing those with and 
without SCI. A study by Jeon and colleagues (Jeon et al, 2003) attempted to answer this 
question; they proposed a low BMR observed in paraplegia and tetraplegia is due to 
reduced FFM, and in tetraplegia, also to reduce sympathetic nervous system activity. 
Differences in BMR (measured by indirect calorimeter) between persons with or 
without SCI become non-significant when the BMR was adjusted for body composition, 
suggesting that the metabolic activity of FFM does not differ in these patients. 
 
Diet induced thermogenesis (DIT) and brown adipose tissue (BAT) 
Decreased DIT may be an important risk factor for weight gain, (D’Alessio et al, 1988) 
and concomitantly mammalian brown adipose tissue (BAT) plays a critical role in 
maintaining energy balance by thermogenesis, (Cannon & Nedergaard, 2004) the 
dissipation of energy in the form of heat. The mechanisms whereby diet stimulates 
energy expenditure are not fully understood and knowledge of the effect and role of 
BAT in SCI patients is limited, (Bucchholz & Pencharz, 2004) Stimulating the energy-
dissipating function of BAT may serve to counteract fat accumulation. (Nedegaard et al, 
2011)
 
The post-meal rise in metabolic rate is a significant contributor to daily heat 
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production and body weight homeostasis, and has a potential role in counteracting the 
development of obesity. 
 
Physical activity level (PAL) 
As a third component of TEE, if neither the BMR, nor the obligatory phase of the diet 
induced thermogenesis (DIT), is different between people with and without SCI. The 
decrease of REE in the SCI population is most likely due to a decreased PAL. However, 
the data on PAL in the SCI population are limited. Data is limited to the cardio 
respiratory response, such as heart rate or oxygen consumption during crutch or walker-
assisted ambulation (Ulkar et al, 2003)
 
or during wheelchair propulsion measured 
during exercise testing (Kolpek et al, 1989). It is not surprising that individuals with 
SCI have significantly lower PAL than those who are able-bodied (Buchholz et al, 
2003; Shizgal et al, 1986; Yamaski et al, 1992). Tetraplegia is associated with lower 
PAL than paraplegia (Dearwater et al, 1985), and participation in sports decreases post 
injury (Tasiemski et al, 2000). Studies seem limited to either measurements of PAL 
indirectly by questionnaire (Dearwater et al, 1985; Tasiemski et al, 2000), or in 
respiratory chambers (Monroe et al, 1998).  
 
Yamasaki and colleagues (Yamasaki et al, 1992) found patients with SCI can perform 
the same as able-bodied individuals if they are actively participating in exercise. But 
generally their TEE was significantly lower when compared to their more active days or 
to the control days of able-bodied individuals. Therefore, individuals with chronic SCI 
should be encouraged to engage in increased frequency, intensity and / or duration of 
structured physical activity to offset population specific sedentary activities. It is 
acknowledged, however, that patients with SCI are engaged in sedentary activities of 
daily living unique to the SCI population, such as pressure relief, bowel programmes, or 
standing in a standing frame which therefore limits the opportunity for exercise. 
 
It is also reported that the TEE was 25 % and PAL was 18 % lower in individuals with 
complete rather than incomplete lesions (Yamasaki et al, 1992). This finding was not 
surprising as complete lesions result in absent sensory and motor function below the 
level of injury and thus might be expected to result in more limited movement. Taking 
this in to account, we can anticipate that individuals with tetraplegia and those with 
complete lesions may be at a particular disadvantage. 
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These factors, in addition to the lack of volitional control below the level of SC lesion 
and the disruption to systemic autonomic control, provide a unique challenge for 
individual to maintain energy balance after SCI. 
 
1.6 Gut microbiota  
The gut microbiota has a tremendous potential to impact our physiology, both in health 
and in disease. They contribute to metabolic functions, protect against pathogens, and 
educate the immune system, and through these basic functions they directly or indirectly 
affect most of our physiological functions (Antoine, 2010). When clinically indicated, 
antibiotics will be used to treat infections, however, the use of antibiotics also have a 
profound impact on the gut microbiota that alters the nutritional landscape of the gut 
and can lead to the expansion of pathogenic species, such as CDI. Changes in 
microbiota can confer resistance to or promote infection by pathogenic bacteria, such as 
CDI. 
 
1.6.1 Role of the gut microbiota in specific disease conditions 
The gut microbiota can influence human physiology, and it is no surprise that there is 
great interest in studying microbiota changes associated with disease states or antibiotic 
use, often referred to as dysbiosis. (Figure 1.5). Gut microbiota dysbiosis has been 
reported to be associated with malnutrition (Smith et al, 2013; Subramanian et al, 2014) 
The relationship between dysbiosis with malnutrition and disease pathogenesis remains 
uncertain at this time. It is not often clear that gut microbiota changes associated with 
diseases are meaningful, and distinguishing between cause and effect is inherently 
challenging. It is intriguing to speculate that dysbiosis may cause disease as we learn 
more about how the gut microbiota can influence the host. It has also been noted that 
the diseased state can lead to changes to the gut microbiota through various 
mechanisms, including changes in eating habits and bowel function, as well as through 
the addition of medication, such as antibiotics.  
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Figure 1.5: Effect of antibiotics on gastrointestinal microbiota, an illustration of dysbiosis 
(McFarland, 2013) 
1.6.2 Manipulating the gut microbiota using probiotics to prevent AAD/CDI  
Probiotics are defined as ‘live microorganisms which, when administered in adequate 
amounts, confer a health benefit on the host’ (WHO, 2002).  In 2014, the definition was 
further reviewed by an expert panel, with just a small change to improve its grammar to 
‘live micro-organisms that, when administered in adequate amounts, confer a health 
benefit on the host’ (Hill et al., 2014).  
 
Probiotics are commonly recommended as an adjunct to prevent AAD / CDI in general 
patients (McFarland, 2006; Segarra-Newnham, 2007; Snydman, 2008). However, no 
probiotic has been demonstrated to be efficacious in the prevention of recurrent CDI 
when studied rigorously. Several recent meta-analyses have indicated that probiotics 
may be effective as a primary prophylaxis for AAD / CDI. (section 1.6.3).  
 
1.6.3 Evidence on the use of probiotic in preventing AAD / CDI 
Probiotics could maintain and restore the gut microbiota balance through receptor 
competition, competition for nutrients, inhibition of epithelial and mucosal adherence of 
pathogens, the introduction of a lower colonic pH favouring the growth of non-
pathogenic species, stimulation of host immunity, or general antimicrobial effects. A 
recent meta-analysis examined randomised, double-blinded, controlled trials of 
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probiotics in the prevention of AAD (Videlock & Cremonin, 2012: pooled relative risk, 
0.53, 95% CI 0.44 to 0.63) and CDI (Johnston et al., 2012), and suggested the use of 
probiotics over a placebo in general patients. (pooled relative risk, 0.34, 95% CI, 0.24 to 
0.49).  
 
A double-blind RCT suggested that probiotics (Lactobacillus casei DN1005) were 
effective in preventing AAD in general patients. The study was conducted on 135 adults 
(n= 66: antibiotics and placebo; n=69 antibiotics and probiotics), and showed that a 
drink containing L. casei, L. bulgaricus and S. thermophilus twice daily prevented AAD 
and diarrhoea caused by CDI (7 of 57 patients in the probiotic group, compared to 19 of 
56 in the control group developed AAD). However, only 135 out of a total of 1760 
hospitalised patients taking antibiotics were randomised in this trial (randomisation rate: 
7.6%), which may limit the applicability of the findings (Hickson et al., 2007).  
 
A few meta-analyses have been conducted to build on the current evidence regarding 
the use of probiotics in AAD in the general patients group. Kale-Pradhan et al. (2010) 
reported a meta-analysis of 10 RCTs (n=1,862) in paediatric and adult patients who 
received a single Lactobacillus strain or placebo for preventing AAD. Lactobacillus 
prophylaxis throughout the antibiotic treatment (5-14 days) reduced the risk of AAD in 
adults but not paediatric patients. Six trials included patients aged 18 years or more, 
whereas four included patients less than 18 years of age (ranging from 2 weeks to 14 
years), while the follow-up period ranged from 2 days to 3 months. The combined risk 
ratio of developing AAD was significantly lower for Lactobacillus vs. placebo (risk 
ratio: 0.35, 95% CI: 0.19 – 0.67). In a sub-group analysis, this held true for adults (risk 
ratio: 0.24; 95% CI: 0.08 – 0.75). Two meta-analyses have examined randomised, 
double-blinded, controlled trials of probiotics in the prevention of AAD in general 
patients (Cremonini et al., 2002; D’Souza et al., 2002).  
 
Another meta-analysis also published in 2012 by Hempel and colleagues included 63 
studies with a total of 11,811 participants. They evaluated probiotics for the prevention 
and treatment of AAD. This review included parallel RCTs that compared probiotic use 
as an adjunct to antibiotic treatment with a concurrent control group. Eighty-two RCTs 
met the inclusion criteria and were included in the analysis. In the 63 trials that reported 
the number of participants with diarrhoea and the number of patients randomised to 
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both treatment groups, probiotic use was associated with a lower risk ratio of 
developing diarrhoea when compared with a control group (Pooled  risk ratio: 0.58; 
95% CI: 0.50-0.68; p <0.001; I2: 54%; risk difference: -0.07, 95% CI: -0.10 to -0.05). 
These results were consistent across a number of sub-groups, and sensitivity analyses 
based on probiotic interventions, participant and setting characteristics, and across 
varying indications for antibiotic use. The researchers reported a beneficial treatment 
effect with a number needed to treat of 13 (95% CI: 10.3 to 19.1). The review 
concluded that probiotics are associated with a reduction in AAD. 
 
A more recent Cochrane review of probiotics for the prevention of CDI in adults and 
children included 23 studies with a total of 4,213 participants. (Goldenberg et al., 2013) 
It was reported that probiotics significantly reduced the risk of CDI by 64%, and the 
incidence of CDI was 2.0% in the probiotic group, compared to 5.5% in the placebo, no 
treatment group, control groups (risk ratio: 0.36, 95% CI: 0.26 – 0.51) (Goldenberg et 
al., 2013). The review concluded that the moderate-quality evidence suggested that 
probiotics are both safe and effective for preventing CDI.   
 
These meta-analyses confirm an odds ratio of 0.39 and 0.37, respectively, in favour of 
probiotic over placebo in preventing AAD. However, the heterogeneity of the studies 
makes it very difficult to draw definite conclusions for disease specific populations, 
such as SCI population indicating further research is needed to determine which 
probiotics, patient’s group and antibiotics are associated with the greater efficacy. 
 
1.6.4 Safety issues of probiotics 
Probiotics, which are regulated as dietary supplements and foods, consist of yeast or 
bacteria. They are generally regarded as being safe, and severe adverse event such as 
mortality or intensive care unit admission have rarely been reported. Safety issues are 
related to bacterial translocation and sepsis, and to the risk of harbouring antibiotic 
resistance transposons that may increase resistance to antibiotics. The theoretical risk is 
the translocation of bacteria from the intestine to other areas in the body, resulting in an 
iatrogenic infection, and two cases of bacteraemia have been reported (Snydman, 2008).  
 
LcS is considered safe to use in clinical settings and has been used in a broad range of 
patients (Matsuzaki et al., 2005; Srinivasan et al., 2006; Stadlbauer et al., 2006). 
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Evidence from human studies suggests that LcS predictably increases the number of 
beneficial intestinal bacteria (Matsumoto et al., 2010), and it has been shown to help 
with constipation (Sakai et al., 2011), to modulate immune function (Dong et al., 
2013) , to reduce the global infection risk (Gleeson et al., 2011), and to reduce the risk 
of diarrhoea (Sur et al., 2011).  
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Summary for chapter 1 
We have discussed the aim of the thesis and included seven first authored papers for 
assessment of PhD by prior publication. The terminology, mechanism, classification, 
epidemiology and financial impact of SCI were discussed in section 1.2. The history of 
SCI centre and dietetic research were presented in section 1.3.  The cause and 
consequence of malnutrition after SCI were discussed in section 1.4 and 1.5. and in 
section 1.6 we report the concept of using probiotics to manipulate the gut microbiota to 
prevent AAD / CDI. Currently, there is limited evidence on the use of probiotic in 
preventing AAD / CDI in SCI patients. The effectiveness of probiotic in preventing 
AAD / CDI in SCI patients will also be discussed in section 3.3. 
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Chapter 2 Identification of malnutrition risk and potential barriers for 
implementing good nutritional care in SCI Centres 
 
The nutritional needs and management of patients who have sustained an SCI and are 
still recovering from the acute trauma and those who are stable and undergoing 
rehabilitation are quite different. This chapter is designed to report the nutrition 
management of SCI patients admitted to a SCI centre. It’s sub-divided into four 
sections, first the prevalence of undernutrition risk after SCI and the use of a nutrition 
screening tool to identify patients at risk of becoming undernutrition will be described 
(section 2.1), then complications related to malnutrition (section 2.2) and the association 
with adverse clinical outcomes in SCI patients (section 2.3: papers 2 and 3) are 
reported, finally, the potential limiting factors for implementing good nutritional care in 
SCI centres are discussed. (section 2.4). 
 
2.1 Identifying patients at risk of malnutrition 
Elia (2003) describes malnutrition as a state in which a deficiency, excess or imbalance 
of energy, protein and other nutrients causes adverse effects on body form, function and 
clinical outcomes. It was refined further by the international consensus committee in 
2010 that varying degrees of acute or chronic inflammation are key contributing factors 
in the pathophysiology of malnutrition associated with disease or injury. (Jensen et al, 
2010)  The committee propose the following nomenclature for nutrition diagnosis in 
adults. 1. “starvation-related malnutrition”, where there is chronic starvation without 
inflammation; 2. chronic disease-related malnutrition”, where inflammation is chronic 
and of mild to moderate degree and; 3. “acute disease or injury-related malnutrition”, 
when inflammation is acute and of severe degree. (Jensen et al, 2010). In 2015, 
European Society for Clinical Nutrition and Metabolism (ESPEN) has published criteria 
for the definition of malnutrition (Cederholm et al, 2015), namely BMI ≤18.5 kg/m2 , or 
weight loss >10% (indefinite of time) or 5% (in 3 months) and BMI <20 kg/m2 for 
patients <70 years or <22 kg/m2 for patients ≥70 years or fat free mass index (muscle) 
(below <15 and <17 kg/m2 in women and men, respectively) to identify malnutrition 
risk.  
 
Previous studies have consistently revealed the inadequacy of any single method or tool 
in assessing a patient’s nutritional status and the use of threshold BMI values as in 
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malnutrition universal screening tool (MUST) may produce false results in SCI patients 
because of changes in body composition after SCI (Laughton et al., 2009).  
 
In the absence of a gold standard, researchers have been led to develop various 
nutritional indices that could be used to identify patients at an increased risk of poorer 
outcomes because of malnutrition. The use of a valid nutrition screening tool (NST) 
could assist the process of accurately identifying those patients who are at risk of 
developing malnutrition. Appropriate identification and early intervention could 
improve clinical outcomes and reduce health-care costs (NICE, 2006). In addition, it is 
well known in the literature that not all tools are suitable for all patients (e.g. patients 
with liver diseases, Morgan et al., 2006) including SCI patients. In the absence of a 
universally accepted definition of malnutrition, it is difficult to establish the validity of 
any newly developed NST. Consequently, it is important to establish the extent to which 
a new NST agrees with previously used and established methods for identifying 
malnutrition (Stratton et al., 2004).   
 
To address this within the SCI population, I previously reported the prevalence of 
malnutrition in SCI patients using the MUST (Wong et al., 2012a: 44·3% of patients 
were undernourished or at risk of undernutrition). Next, in the same group of patients, 
we validated a disease specific tool, the SNST (Wong et al, 2012b; figure 2.1) against 
the pragmatic reference standard of a full dietetic assessment, assuming that an 
assessment by a dietician is the most likely to be accurate, as it reflects additional 
knowledge and training (Wong et al., 2012d: I found that the SNST is an acceptable and 
reliable nutrition screening tool with reasonable reproducibility and valid when 
compared with another validated nutrition screening tool (MUST) and a full dietetic 
assessment. (Wong et al., 2012b) The SNST had substantial agreement with MUST (k: 
0.723, 95% confidence interval (CI): 0.607–0.839) and the dietitian assessment (k: 
0.567, 95% CI: 0.434–0.699). The SNST had a moderate to substantial reliability (inter-
rater reliability: k: 0.5, 95% CI: 0.2–0.8; intra-rater reliability: k: 0.64, 95% CI: 0.486–
0.802). When compared with dietetic assessment, the SNST had a numerically lower 
specificity (76.1% vs 80.4%) and similar agreement to MUST (k: 0.57 vs 0.58) but 
SNST showed a numerically higher sensitivity (85.7% vs 80.4%) and a numerically 
higher negative predictive value (92% vs 89.2%) than MUST.)  Finally, I also 
demonstrated that undernutrition-risk score using the SNST, were associated with 
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adverse clinical outcomes, including length of hospital stay and 365 days mortality rate 
after admission (Wong et al., 2013). 
 
Although the SNST is not superior to the widely used generic nutrition screening tool 
(the MUST). My data does however confirm that the SNST is valid to screen SCI 
patients’ nutritional risk. (Wong et al, 2012b) The SNST is a locally developed 
screening tool, which has been used in some major UK SCI centres including the NSIC 
at Stoke Mandeville Hospital and the Duke of Cornwall Spinal Injuries Centre at 
Salisbury District General Hospital since 2004. There was a reluctance to abandon this 
disease specific tool, which was familiar to the users. Recently, more SCI centres (who 
are not routinely screening their patients) are now considering using SNST for nutrition 
screening. I consider that my data permits us to condone this more comfortably than 
was previously the case. In addition, I see this as something of an organisational 
advantage as to continue to use the SNST in SCI centres where it is established is easier 
than switching to an alternative and preferable to having several tools in use in a small 
discipline. The UK NICE highlights the importance of using a validated NST, and 
MUST is only one of the recommended choices. I failed to find any published literature 
indicating whether in SCI patients  should use a generic NST or a disease specific NST. 
I hope my (now published) data helps to fill this void and add insight into future clinical 
research in SCI medicine. I hope that promotion of this tool will convince other SCI 
professions to use a common disease specific NST. 
 
It was noted nutritional therapy is seen to be under-utilised in the SCI centres. Several 
organisational factors, I published previously, including sub-optimal dietetics provision 
(section 1.3.3; Wong et al., 2012c), inadequate nutrient intake (Wong et al., 2012c), 
together with poor nutritional knowledge (Wong et al., 2012d) are thought to be barriers 
of implementing good nutritional care.    
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Figure 2.1: The Spinal Nutrition Screening Tool (Reproduced from Wong et al, Eur J Clin Nutr 2012; 66: 382-387) 
 
 
 
 
 
 
 
 
 
 
 
 
SCI: spinal cord injury; C1-C8: Cervical SCI; T1-12: Thoracic SCI; L1-L5: Lumbar SCI; S1-S5: Sacral SCI 
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Many patients, AHPs and hospital managers do not realise how common malnutrition is 
within hospitalised patients (Wong et al, 2012d: that 60% of doctors and 29.3% of 
nurses are correct in estimating the prevalence of malnutrition).  I previously proposed 
that poor nutritional knowledge among SCI nurses and doctors is probably another 
barrier to implementing good nutritional management (Wong et al, 2012d; without 
proper training it can be assumed that front line healthcare staff will continue to fail to 
identify patients at nutritional risk, and subsequently to offer appropriate choice of 
treatment (Wong et al., 2012c).   
 
In addition, despite high awareness of obesity as a medical significant issue (NICE, 
2006a), the magnitude of the obesity epidemic remains high and is worsening, 
particularly in patients with SCI (Wong et al, 2012a: 45% of SCI patients are at-risk of 
over-nutrition) A more detailed understanding of knowledge, attitudes and practice of 
SCI staff is necessary to determine the best way to facilitate the contribution of SCI 
medical staff in addressing obesity after SCI. Although there are standard published 
recommendations for SCI management and optimal staffing levels (Paper 5), these 
documents do not make specific recommendations on obesity management. In 2012, a 
study was conducted to determine the nutritional knowledge, attitudes and practices of 
medical staff towards weight management in patients with SCI so that it could be 
decided whether additional training might improve detection and treatment of 
malnutrition in SCI patients.  (Paper 4) 
 
Paper 4: Wong S et al (2015) Knowledge, attitudes and practices of medical staff 
towards obesity management in patients with spinal cord injuries: an international 
survey.  Spinal Cord 53: 24-31.  
 
During October 2012 and May 2013, I surveyed senior medical staff working in 23 SCI 
centres from four European countries (Belgium: n=3, the Republic of Ireland: n=1; the 
Netherlands: n=8, and the United Kingdom: n=11, with a covering letter addressed to 
the local medical lead explaining that findings would be used to identify current 
knowledge, attitude and practices of medical staff and to identify areas for 
improvement. 
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The overall SCIC response rate was 78.4% (18/23 SCICs; 59 individual responses, 2-12 
responses per SCIC, 63.6% in the United Kingdom (n=7), 66.7% in Belgium (n=2), 
62.5% in the Netherlands (n=5) and 100% in the Republic of Ireland (n=1). Whilst the 
majority of the respondents felt that they are confident in dealing with overweight 
(74.5%) and obese (66.1%) SCI adults, less than half (44.1%) are confident in treating 
overweight and obese SCI children. The respondents also highlighted the need to 
practice malnutrition (obesity) prevention and management but that there was a lack of 
suitable training on offer. (Paper 4)  No junior/trainee doctors reported that they had 
received formal training in obesity management of SCI patients and only 2 (6.3%) 
senior doctors reported that they had formal training in this area.  
 
SCI specialists have been identified as important potential contributors to the prevention 
and treatment of overweight and obesity, in part, because of continued involvement 
during rehabilitation. SCI medical staff are therefore in a unique position to provide 
guidance to patients. In the UK and Republic of Ireland, SCI consultants will continue 
to see their patients as part of a life-long follow up. They are the most frequently used 
source of information about weight control and are perceived to be the most reliable 
formal source of information.  
 
Among medical staff, knowledge, attitudes and practices in the management of obesity 
have been studied in various English-speaking countries, especially amongst General 
Practitioners (Thuan & Avignon, 2005). However, despite high awareness of obesity as 
a medically significant issue (Kristeller & Hoerr, 1997), the magnitude of the obesity 
epidemic remains high (NICE, 2006a) and is worsening, particularly in SCI patients. 
(Wong et al, 2012a) However, weight management is not commonly offered to SCI 
patients, at least not in the UK. (Wong et al, 2011)  
 
The main strength of this study is that it is the first official European survey conducted 
in four European SCI centres which obtained an overall 78.4% response rate from 
across four European countries. Therefore it was not possible to compare the present 
study’s response rate with the literature.  
 
This study has a number of limitations. The selection of the SCICs in each country was 
at discretion of the principal investigators. Although the number of SCICs per country 
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was small. The survey was sent to all SCI centres with a high response rate, and with no 
data / response were excluded from the analysis .Therefore, I believed the results 
derived from this sample of SCICs could be considered representative of each country 
and I hope the data is generalisable to other European SCI centres. 
 
Formal sample size calculation was not performed as I surveyed all SCI centres. The 
present study reported a response rate of 78.4%, the response rate was comparable in 
literatures. However, I did not address the non-response bias. It would be recommended 
in future study to assess non-response bias formally. 
 
The centres’ response rate varied from 2–12 responses per SCIC, some larger centres 
may be over-represented in the results. In addition, our technique of secondary 
invitation of respondents by selected lead individuals within a SCIC could introduce 
selection bias and I acknowledge this; however, guidance was provided to them to 
circulate the questionnaire to all medical staff, with varying degrees of experience and 
special interest, working in the SCI centres. Although the respondent sample size 
(n=59) was small, I feel that this still reflects the views of SCI doctors working in 
SCICs. To our knowledge, this represents at least 46.8% of all senior medical staff in 
the UK and Ireland SCICs (15 out of a total 32 centres) which is comparable with the 
literature (53% response rate).  
 
Apart from the UK, I did not include junior staff from Ireland, Belgium and the 
Netherlands. There was a predominance of respondents from the UK (n=40) compared 
to non-UK respondents (n=19). Although this arguably over-represents from one 
country’s perspective, it does not reflect the reality of staff-mix in the SCI centres. The 
number of senior medical staff surveyed was comparable in the UK and non-UK centres 
(14 vs 19). 
 
The present study’s questionnaire contains 37 items. It was developed based on 
previous published literatures. (Al-Ghawi et al, 2009; Campbell et al, 2000; Bocquier et 
al, 2005; Fogelman et al, 2002) Therefore, I believe the questionnaire is likely to be 
valid and reliable.   
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In summary, this was the first study to document the need for obesity management 
among SCI professionals. Limited knowledge and experience among medical staff 
together with variation in dietetic provision (paper 4, 5) in SCIC are probable barriers to 
effective weight management for SCI patients. Our results indicate that more structured 
teaching about obesity classification and its treatment should also be provided for all 
front line staff, especially more senior staff that has previously been denied this 
opportunity. Without proper guidelines and training, it is unlikely that healthcare staff 
will have sufficient knowledge to identify at-risk patients or to offer appropriate 
treatment.  This study reinforces the need to consider collaborating with national 
professional bodies to develop SCI-specific weight management guidelines which 
include clear guidance on optimal dietetic service provision within the SCICs. 
 
2.2 Potential limiting factors for implementing good nutritional care in SCI centres 
 
The potential barriers limiting the implementation of good nutritional care and in SCI 
patients were discussed in section 2.1. These include sub-optimal and variation in 
dietetic resources within UK SCI centres, (section 1.3.2), and poor knowledge among 
staff at SCI centres concerning the management of malnutrition (section 2.1). In this 
section, I will discuss specific limitations for conducting nutrition research in SCI 
patients with emphasis on my research. These include lack of universal diagnostic 
criteria for CDI, and diarrhoea management practices varying among SCI centres 
(section 2.2.1), lack of a universal definition of malnutrition and diarrhoea (section 
2.2.2) and limited evidence available for the use of probiotic in SCI patients (section 
2.2.3 and section 2.2.4). Paper 6 will be used to support this section. 
 
Paper 6: Wong S et al. Survey on the use of probiotics in preventing antibiotic 
associated diarrhoea and Clostridium difficile associated diarrhoea in spinal cord 
injuries centres. Int J Probiotics and Prebiotics 10, 85-90. 
 
2.2.1 C. difficile - practice varies between SCI Centres – dose SCI centre have 
standardised C. diff infection policy? 
 
Although there is promising evidence to support the use of probiotics to prevent AAD 
and CDI (section 1.4.1), there are no recommendations published to provide guidance to 
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physician regarding the use of probiotic in preventing CDI and AAD in SCI patients 
and consensus exists on optimal diagnostic criteria for CDI.   
 
In 2014, I surveyed nine SCI centres from four European countries (UK, Ireland, the 
Netherlands and Belgium) with an aim to investigate SCI centres’ CDI management 
strategies (including diagnostic procedures and presence of national surveillance) (paper 
6). In addition, it was also documented whether they stocked probiotics, and the reason 
for the use of probiotics.  
 
All nine SCI centres responded to the survey. It was found the current diagnostic tests to 
detect the presence of C. difficile or its toxins in stools are not uniform. Only five out of 
nine SCICs reported they have a CDI policy. Five SCICs reported CDI cases and the 
median CDI cases per 10,000 days were 0.56 (range: 0-1.08). The methods for 
diagnosing CDI, culturing C. diff, definition of diarrhoea and treatment options are 
varied and these are summarised in Table 2.1.  
 
Four out of nine (44.4%) centres did not stock any probiotic products. Three SCICs 
stocked only one probiotic product, and two SCIC stocked more than one probiotic 
product.   Of the five SCICs that stocked probiotics, the products were used for 
preventing AAD (n=4) and CDI (n=2) and/or constipation (n=1). 
 
The stocking of probiotics for the prevention of AAD/CDI was not found to be common 
in SCI centres (section 2.1.3), and the definition of diarrhoea (section 2.1.2) and 
management of CDI varied, suggesting inconsistency in patient’s care and potentially 
missed opportunity in improving patient’s care. The results highlighted the need for a 
standardised definition within this vulnerable population group. Since the study was 
published, I have discussed with the ISCOS about setting a universal definition of 
diarrhoea / C. difficile management standards, as this would not only help in identifying 
and treating SCI patients but also in future AAD/CDI research (for common study 
outcome). 
 
The survey (in paper 6) had some limitations. Firstly, the selection of the SCI centres in 
each country was at the discretion of the principal investigator and the number of SCI 
centres per country was small. I acknowledged the snowball sampling technique was 
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not ideal (see as per paper 4) However, the SCI centres selected represented 
approximately 40% of the SCI centres in Belgium, the UK and the Netherlands, and 
100% within the Republic of Ireland. Therefore, I believe results derived from this 
sample can be considered relatively representative of each country.  
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Table 2.1: Summary of CDI management in SCI centres (Paper 6) 
 
     Centre 1      Centre 2      Centre 3       Centre 4     Centre 5      Centre 6      Centre 7     Centre 8     Centre 9  
     
C. difficile policy      *          Yes  Yes          *           Yes Yes     Yes           Yes Yes 
C. difficile outbreak       No           No  No          *            No  No      No            No No 
Number of CDI in SCIC       0            *   0          *              2    1        1            1     0 
CDI cases per 10,000 patient days (SCIC)     0            -   0          -           0.56 1.08      0.63         0.76    0 
C. difficile diagnostic criteria      1            1            1,5,6          1              1    1        1             1     1  
Medium for culturing C. difficile
b
      1            1  1          1              3    4        1             4     1  
First line treatment of CDI 
c
      1            2  2          2              1    2        1             2     1 
Criteria for diarrhoea
d
       1           2  3          2              1    4        1             1     2 
 
CDI: Clostridium difficile infection; SCIC: spinal cord injury centre 
 
a
C. difficile diagnostic criteria: 1: Enzyme immunoassays (EIA) for C. diff toxin A and / or toxin B; 2: EIA for C. diff toxin A only; 3: Cytotoxicity test; 4: culture for toxin 
producing C. difficile; 5: Enzyme for C. difficile- specific glutamate dehydrogenase; 6: PCR 
b
1.Cysloserin-cefoxtin-fructose agar; 2: Cycloserin-cefoxitin-mannitol agar; 3: Brazier medium; 4: Polymerase chain reaction 
c
First line treatment of CDI: 1: Vancomycin 125mg 6 hourly PO for 10-14 days; 2: Metronidazole 800mg loading dose then 400mg 8 hourly PO for 10-14 days 
d
Definition of diarrhoea: 1: ≥2 watery liquid stools type 5,6 or 7 (Bristol stool scale) over 24 hours; 2: 2: ≥ 2 stools per day for ≥3 days; 3: ≥ 3 loose or liquid stools per day; 4 
other 
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2.2.2 Lack of a standardised definition for malnutrition risk and diarrhoea 
 
There is no universal agreement of the definition of malnutrition risk (section 2.1) and 
malnutrition. Elia (2003) describes malnutrition as a state in which a deficiency, excess 
or imbalance of energy, protein and other nutrients causes adverse effects on body form, 
function and clinical outcomes. This was refined further by the International Consensus 
Committee in 2010 that varying degrees of acute or chronic inflammation are key 
contributing factors in the pathophysiology of malnutrition associated with disease or 
injury
 
(Jensen, 2010). The committee proposed the following nomenclature for nutrition 
diagnosis in adults: (1) ‘starvation-related malnutrition’, where there is chronic 
starvation without inflammation e.g. medical conditions like anorexia nervosa; (2) 
‘chronic disease-related malnutrition’, where inflammation is chronic and of a mild to 
moderate degree such as organ failure or pancreatic cancer; and (3) ‘acute disease or 
injury-related malnutrition’, when inflammation is acute and of a severe degree such as 
major infection, burns, trauma or head injury (Jensen et al., 2010). 
 
Diarrhoea is thought to be clinically significant if there are more than three loose stools 
per day (Hogenauer et al., 1998; O’Donnell et al., 1990). However, our recent survey in 
four major European SCI centres found that the definition of diarrhoea varies among 
SCI centres. (paper 6) Up to four different definitions of diarrhoea were reported from 
nine SCI centres. Of nine centres surveyed, four SCI centres use  ≥2 watery liquid stools 
type 5,6 or 7 (Bristol stool scale) over 24 hours; Three SCI centres use  ≥ 2 stools per 
day for ≥3 days; One SCI centre uses ≥ 3 loose or liquid stools per day and one SCI 
centre reports they do not a have standardised definition but are using clinical 
judgement.  With different diagnostic criteria, there is the potential for making 
inconsistent clinical diagnosis and false positive results for CDI and increases 
inconsistency in CDI research.   
 
Indeed, using different criteria definitely creates inconsistency in both making a clinical 
diagnosis and has an implications on research outcomes. Using a standardised definition 
of study outcome including diarrhoea and malnutrition, would improve the quality of 
future research studies, especially systematic reviews and meta-analyses as currently it 
uses inconsistent criteria. It is recommended to use a standardised criterion for 
diarrhoea, CDI and detecting malnutrition risk as this would facilitate a variety of other 
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projects (clinical and research), ranging from clinically based nutrition intervention 
studies to health economic studies, including an investigation into the cost of 
malnutrition in SCI patients. 
 
2.2.3 SCI centres stocking of different probiotic supplements  
I found five (55.5%) out of nine centres stocked probiotics. Five different types of 
probiotic strains were identified. Although, four probiotics strains were reported by one 
centre’s clinician as being of use for AAD/CDI prevention, only one of four probiotic 
strains (LcS) had been studied for use in a SCI population paper 3).  
 
Different SCI centres tended to stock different types of probiotics, and the diagnostic 
criteria for diarrhoea varied amongst SCI centres, suggesting that SCI clinicians need to 
be reminded of the concept that the probiotic effect is strain-, dose- and disease-specific 
and there is a need for standardised policy for CDI. It also highlights the importance of 
reviewing the evidence for each probiotic before offering it to SCI patients as the 
probiotic effect is strain-specific (Goldenberg et al, 2013). A systematic review  was 
planned and a meta-analysis to assess the effect of probiotics in preventing and treating 
AAD and CDI in the SCI population (Papers 7). A systematic review protocol was 
published in December 2015 (Paper 7) 
 
2.2.4 Limited evidence on the use of probiotics in preventing AAD/CDI in the SCI 
population 
In this section, I will focus on assessing the quality of evidence on the use of probiotic 
in preventing AAD / CDI in SCI populations. Two key papers (paper 6 and paper 7) 
will be used to support the section.   
 
Paper 7: Wong S et al. (2015)  Effectiveness of probiotic in preventing antibiotic 
associated diarrhoea (AAD) and Clostridium difficile associated diarrhoea (CDAD) 
in patients with spinal cord injury: a protocol of systematic review of randomised 
controlled trial. Syst Rev 24, 170. Doi: 10.1186/s13643-015-0159-3. 
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Drinking probiotics (paper 3) is often recommended with antibiotic use to maintain a 
healthy gut microbiota and to prevent harmful bacteria overgrowth, such as by C. 
difficile which could overwhelm the gut and cause CDI (section 1.6.1). However, the 
evidence of its use in SCI patients is currently unknown. Therefore, the aim of this 
section was to report our plan to evaluate the evidence on the use of probiotic in 
preventing AAD / CDI in SCI patients. 
 
A systematic literature review to determine whether the probiotics that were stocked 
were supported by any clinical research was undertaken. Of five different probiotic 
strains reported, I performed a systematic literature search restricting our search to 
randomised controlled trials that assessed probiotics in SCI patients exposed to 
antibiotics. I searched the Cochrane Central Register of Controlled Trials, Health 
Technology Assessment Database; CINAHL; PsycINFO; EMBASE; Medline; AMED 
and DARE from the date of inception to Feb 2015 using the following terms (with 
synonyms and closely related words): “spinal cord injuries” combined with  “antibiotic-
associated diarrhoea” and “probiotic”.  Our search identified only one study reporting 
evidence of probiotic benefit against AAD in an SCI population, which was one of 
those probiotics: LcS.
 
(Paper 3)   
 
Our review did not find any studies conducted in SCI populations that investigated use 
of probiotics for preventing or treating CDI and constipation in the SCI population, 
although there are several studies with the general population (section 1.6.3).  I found 
that LcS and L. Casei DN-14001 appear to be the choice of probiotic for prevention of 
AAD / CDI in SCI centres. Overall, no probiotic was supported by a strong evidence 
base, mainly due to the lack of consistent benefit from different studies.  
 
Only 25% and 50% of SCICs stocked LcS and L. Casei DN-14001, respectively, 
whereas 50% of SCICs stocked at least one probiotic that was supported by low or no 
evidence. These results suggested that a majority of SCICs stock a probiotic that lacks 
reliable evidence. Although I only found only one study reporting the efficacy of 
probiotic in preventing AAD in SCI patients, the other probiotic strains may also be 
effective.  
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Recent meta-analyses from general population examining randomised, double-blinded, 
controlled trials of probiotic in the prevention of AAD (Cremonini et al, 2002; D’Souza 
et al, 2002; Hempel et al, 2012; Goldenberg et al, 2013)  and CDI (Goldenberg et al, 
2013)  suggested that the use of probiotics could reduce the occurrence of diarrhoea 
when compared to placebo. However, the heterogeneity of studies varies in disease 
conditions (e.g. SCI), probiotic strains, dose and duration of probiotic and the definition 
of diarrhoea makes it very difficult to draw definitive conclusions.    
 
Most previous probiotic research has involved small, single centre studies of variable 
quality, and even when a meta-analysis is carefully performed it is limited by the quality 
of the included studies, and therefore could introduce additional bias through study 
selection and data pooling methods.  Although the study by Allen et al. (2014) is by far 
the largest RCT, they only used two strains of probiotic bacteria (LcS and B. bifidum) 
within a specific patient group.  With newly published data and conflicting evidence to 
support the association of reduced rates of AAD with probiotic use, it is difficult to 
draw definite conclusions for the SCI population.  
 
This study has a number of limitations. The selection of the SCICs in each country was 
at the discretion of the principal investigators. At present, the number of SCI centres per 
country was small. The study authors justified to include one SCIC for each country 
with fewer than 10 million inhabitants or fewer, two for countries with between 10 and 
20 million inhabitants, and four for those with more than 20 million inhabitants, with a 
balance between academic and non-academic institutions. All survey SCI centres 
responded. Therefore, results derived from this sample of SCICs could be considered 
representative of each country and hope the data is generalisable to other European SCI 
centres. 
 
The SCI centres selected represented approximately 40% of the SCICs in the Belgium, 
UK and the Netherland, and 100% in the Republic of Ireland.  Therefore, results derived 
from this sample of SCICs could be considered representative of each country. (at least 
in this four Western European Countries) and I hope the data is generalisable to other 
European SCI centres. The present study reported a response rate of 100%. Therefore, 
the author did not address the non-response bias in the present paper. The sample 
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selected was representative, at least to the UK, Belgium, the Netherlands and the 
Republic of Ireland. All surveys were sent to all medical leads working in the SCI 
centres. It would be recommended in future studies to survey all SCI centres in the 
country of interest. 
 
In summary, there is increasing evidence to support the preventive role of probiotics in 
AAD. (Cremonini et al, 2002; D’Souza et al, 2002; Hempel et al, 2012; Goldenberg et 
al, 2013) However, they have also highlighted some common limitations, such as 
heterogeneity between studies, poor documentation of probiotic strains, and a lack of 
assessment of probiotic-specific adverse events. Identification of the population who 
may benefit most from probiotic therapy remains unclear, and further research is needed 
to determine the optimal dose of probiotic therapy, as well as the comparative 
effectiveness of different probiotic regimens in specific patients group.  
 
 
Summary for chapter 2 
In chapter 2, I have discussed how to identify SCI patients at risk of malnutrition 
(section 2.1), and the cause and consequences of malnutrition were discussed in section 
2.2 and 2.3. In addition, the potential limiting factors for implementing good nutritional 
care in SCI centres were discussed in section 2.4, these included CDI practice variation 
amongst SCI centres, and lack of standardised definition for malnutrition and diarrhoea. 
Currently, there is limited evidence on the use of probiotic in preventing AAD / CDI in 
SCI patients. To guide SCI clinical practice, I devised a systematic review protocol to 
investigate the effectiveness of probiotics in preventing AAD / CDI in SCI patients but 
unfortunately, limited studies were identified to indicate the benefits (or not) on the use 
of probiotics in SCI patients.  
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 Chapter 3 Nutrition interventions in SCI Patients with malnutrition risk 
Many studies from general populations have suggested that the clinical consequences of 
malnutrition such as length of hospitalisation (section 2.3); obesity (section 3.1), and 
diarrhoea (section 2.3; 3.3) could be reduced, avoided or reversed by appropriate 
nutritional interventions. 
  
The evidence on the use of different nutritional intervention in SCI patients is currently 
limited by various factors, mainly related to limited resources invested in nutrition and 
dietetic research for SCI patients. (section 1.3.2)  Nevertheless, limited trials have been 
published in this field. To date, studies included the use of specific amino acid in 
healing pressure ulcers (Brewer et al, 2010: arginine supplement group had a significant 
shorter healing time when compared with control group: 10.5 + 1.3 weeks v 21 +3.7 
weeks, p<0.05)); the use of cranberry in preventing or treating urinary tract infection 
(Opperman et al, 2010: that no evidence to support the use of cranberry could prevent 
urinary tract infection) and weight management clinic for SCI patients (Chen et al, 
2006; Wong et al, 2011; Rimmer et al, 2013: that structure weight management 
programme could help SCI patients to lose weight without compromising lean body 
mass).  The trials results are summarised in Table 3.1 
 
In this chapter, three original nutrition studies I tried in our SCI patients are discussed. 
These include the role of nutrition interventions using a range of different interventions 
to treat/prevent nutrition related complications, including using bariatric surgery to treat 
morbidly obese SCI patients (section 3.1), use of nutritional supplements in patients at 
malnutrition risk (section 3.2), and the use of probiotic Lcs to prevent AAD / CDI and 
AAD in SCI patients (section 3.3).   
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Table 3.1: Selected nutritional trials in spinal cord injured patients 
 
Author  Objective  Research  Setting  sample size data   Main   Conclusion  
Date      approach subject    collected  results 
Journal 
 
Brewer et al To determine whether case-control SCI patients 35  Ulcer healing intervention group had a Arginine may aid pressure 
2010  or not the use of an  study  with pressure  18 intervention time  significant shorter mean ulcer healing in SCI patients 
J Wound Care arginine-containing  ulcer    receiving 9g of   ulcer healing time when 
  Nutritional supplement     arginine/d until   compared with control 
  in pressure ulcer       full healing    10.5 +  1.3weeks vs. 
  management      occurred    21 + 3.7 weeks, p<0.05 
         17 historical  
         control 
 
 
Opperman  To determine whether Literature  SCI patients 5 studies   Incidence of  3 studies found no   Mixed messages 
2010  the literature support review    436 patients UTI  significant effect  More rigorous clinical  
Spinal Cord the use of cranberry in     388 prevention   1 reported significant research is needed 
  Preventing or treating     of UTI     reduced biofilm load 
  urinary tract infection      48 treating UTI   1 reported fewer  
  (UTI)           UTI 
 
Rimmer JH et al Examined the effect of a RCT  Adult with 102  Body mass index   Significant reduction in Web-based remote 
2013  9 months remote   3 arms  physical   24 SCI   B-PADS score   BMI; B-PADS score in coaching tool could be 
Am J Phy  telephone-based weight   disabilities (9 control; Physical activity,   POWERS group   effective strategy for  
Med Rehab management program     7 POWERS; mins/week   and   assisting over-weight adult 
         6 POWERS+) Nutrition score   POWERS+ group  with physical disabilities in 
maintaining or reducing weight 
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Author  Objective  Research  Setting  sample size data   Main   Conclusion  
Date      approach subject    collected  results 
Journal 
 
 
 
Chen et al To assess the   A single group Adult with 16 chronic weight, body  Significant reduction in  weight management clinic 
2006  effectiveness of weight  uncontrolled chronic SCI SCI patients mass index body mass index,  c covering diet and exercise can 
Spinal Cord loss program  trial      skinfold, blood anthropometric   help SCI individual to loose 
           Pressure, lipid measurements and fat weight without compromising 
           Profile, nutrient mass and improvement total lean body mass. 
           Intake,   in diet quality and  
           Psychosocial and  psychosocial and  
           Physical function  physical function 
 
Wong et al To assess the   A single group Adult with 38 SCI  body mass index   Significant reduction   Simple dietetic intervention 
2011  effectiveness of weight uncontrolled SCI  patients  (BMI), mid-upper   in weight, BMI, TSF, can help SCI people to loose 
Food Nutr Sci management clinic trial       arm circumference    systolic blood   weight without compromising 
           (MUAC), triceps   pressure.   lean body mass. 
           Skinfold (TSF), 
           Mid arm muscle 
           circumference, 
           Blood pressure  
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3.1 Using oral nutritional supplements and vitamin and mineral supplements in 
SCI patients at under-nutrition risk   
 
Medical nutrition can support individuals who cannot meet their nutritional 
requirements through a normal diet and / or help them to manage their condition. ONS 
are an essential part of a care pathway for those patients who are unable to support 
themselves through conventional nutrition, as well as being a clinically and cost-
effective way to manage malnutrition when prescribed and monitored appropriately. 
(NICE, 2006b) SCI patients at risk of undernutrition may require dietary supplements 
such as oral nutritional supplements (ONS) and/or vitamin and mineral supplements 
(VMS) in order to correct their nutritional deficits. Opperman et al (2010) reported that 
the use of dietary supplements was high in SCI patients living in the community, but 
prior to 2013, there is limited literature reporting on the usage of supplements in an in-
patient setting (SCI centre). Therefore, this section discusses whether nutritional 
supplements are used appropriately and Paper 1 is used to support this section. This 
study also aimed to assess food intake and to establish the prevalence of ONS and VMS 
usage in a representative sample of SCI patients from the NSIC; and to identify the 
characteristics of supplement users.  
 
Paper 1: Wong S et al. (2013) Nutritional supplement use in patients admitted to 
spinal cord injury centre, J Spinal Cord Med 36, 645-651.  
 
In an attempt to understand the utilisation of nutritional supplements in a SCI centre, I 
conducted a survey during February 2012 to access the food intake and use of ONSs in 
the NSIC.  Sixty-seven of the 73 returned questionnaires included a food record chart. 
The meal intake data was collected via a food record chart (nil by mouth, less than half, 
half, more than half and all eaten), this was used in our previous study (Wong et al., 
2012e) and the method had been validated by Hiesmayr et al in the European Nutrition 
Day study. (Hiesmayr M et al, 2006) Twenty-one of the 67 (31%) patients consumed 
three full meals a day. Approximately one in ten patients (7 of 67) ate less than half of 
their breakfast. Eighteen (26.8 %) patients were found to miss one or more meals.  A 
significantly higher proportion of patients missed their evening meal rather than either 
breakfast or lunch. (28.3%, 10.4%, and 8.9% respectively, χ2: 11.67, p =0.003) Snacks 
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were not provided to the great majority of patients (90%), and 31 (42.5%) of patients 
reported that they required assistance to eat. 
 
I found that the use of a ONS and VMS was common in SCI patients in an in-patient 
setting (19.1% took an ONS and 46.5% a VMS), especially in older patients with an 
undernutrition risk (62.1%) (paper 1). The study also found a high prevalence of 
patients at risk of undernutrition using the SNST (47.9%) (Wong et al, 2012b), which is 
comparable with our previous findings (Wong et al., 2012a).  
 
Undernutrition risk (SNST score ≥11,  p=0.005), low serum albumin (<30g/L, p=0.012) 
and haemoglobin level (<11, p=0.043) were identified by the univariate logistic 
regression analysis as predictors of ONS usage. 
 
Food is the treatment for most malnourished patients in hospital. I found that more than 
one-third (39.8%) of patients did not eat all the food served. Based on the UK’s estimate 
of average requirements (EAR) and reference nutrient intake (RNI) (Department of 
Health, 1991), the deficit from a single missed meal would be equivalent to 300-600 
kcal and 15-20g protein per day (16-33% of daily requirement).  In addition, I found 
that snacks, which can contribute substantially (e.g. 400kcal, 6g protein, or ~15% of 
daily requirement), were not provided to the majority of patients (90%), indicating an 
important missed opportunity in SCI patients with additional nutritional requirements, 
such as pressure ulcers. 
 
It is known that the prevalence of supplement use has increased over recent years in the 
UK. One of the largest studies of its kind, the UK National Dietary and Nutrition 
Survey (NDNS) (Henderson et al., 2003) assessed the UK general population’s diet, 
nutrient intake and nutritional status via a continuous, cross-sectional survey. The 
NDNS reported that the number of respondents (n=1,724) taking supplements had 
increased, with 40% of women and 29% of men taking some form of dietary 
supplement in 2000/2001, compared to 17% of women and 9% of men in 1986/1987. 
The NDNS’s were from the general population, our present study found a higher 
proportion of patients (50% of females and 45.7% of males) to be receiving a VMS, but 
the very fact of hospitalisation in SCI centre is obviously important. Increasing interest 
in normalising the micronutrient profile to improve health outcomes may also have 
74 
contributed, such as those with pressure ulcers. (NICE, 2005; Consortium of Spinal 
Cord Medicine, 2014)  
 
The main limitation of our study was that only one day’s food intake was assessed, and 
therefore assumptions have necessarily been made concerning food provision and net 
intake across a sometimes very prolonged hospital stay. It is expected a larger sampling 
of their food intake, than a single data collection, would provide stronger evidence to 
permit a more conclusive comparison with the national standards (Department of 
Health/Public Health England, 2014). However, I believe that it is highly probable, had 
we asked for longer diary data, that this would have adversely affected the response rate 
and itself diminished the generalisability of the conclusions for different reasons. 
Indeed, the uses of computer technology such as a pictorial food diary, weight food 
diary or smart phone applications are worthwhile to consider in future studies, but this is 
not applicable for the present study as this was a clinical audit. 
 
I believed this was the first study formally reporting the pattern on the use of nutritional 
supplements in patients admitted to a SCI centre. This would make formal sample size 
calculation difficult. The sample size of the present study (n=73 out of 105 respond) are 
comparable with other published literatures. (Opperman et al, 2010; Wong et al, 2012) 
The present study survey (using a questionnaire) all patients admitted to the NSIC. 
Although I failed to perform sample size calculation, I believe the sample size 
represented a significant proportion of samples studied and comparable to other 
published studies. The percentage of female participants (19.2%) are similar to 
published literature (20% of SCI population were female, Ho et al, 2007) describing 
SCI population, suggesting the risk of non-response bias is small. The inevitable 
disabilities and the need for extended hospitalisation for acute care and rehabilitation in 
this group of patients renders extrapolation from generic hospital populations unwise. I 
believe that when compared with the published literature in SCI population, our sample 
size and response rate lends sufficient weight for our conclusions to be meaningful, that 
use of ONS and VMS is common amongst SCI population, if used appropriately in 
those at risk of under-nutrition, this could be a cost effective treatment. (Opperman et 
al., 2010).  
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Formal ethical permission to conduct the study was not required by the institution’s 
review board as this was considered a clinical audit not involving active patient’s 
participation.  
 
In conclusion, the data from this study indicates that nutrient intake from hospital meals 
alone was often insufficient to meet patients’ requirements and the use of ONSs and/or 
VMSs is likely to be beneficial to protect against and to treat both macro- and micro 
nutrient deficiencies and their related complications. Given that a high proportion of 
SCI patients will require assistance to eat (especially true for complete-tetraplegic 
patients), a further study should focus on whether additional feeding assistance could 
improve patients’ food intake in this context. 
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3.2 Treating morbidly obese SCI patients   
Obesity has become an unavoidable issue in the SCI population due to their enforced 
inactivity secondary to paralysis and subsequent change in body composition. (section 
1.5.5) Whilst, limiting trials report the effectiveness of dietary modification in treating 
obesity (Chen et al, 2006; Wong et al, 2011), there was limited evidence in reporting 
how dietitians could contribute in treating morbid obese patients with SCI. This section 
will discuss how dietitians (as part of multidisciplinary team) could contribute in 
treating morbidly obese SCI patients using bariatric surgery (section 1.2.1 and 2.1). 
Paper 2 will be used to support this section.  
Paper 2: Wong S et al. (2013) Morbid obesity after spinal cord injury: an ailment 
not to be treated? Eur J Clin Nutr 67, 998-999.  
 
There are limited data on the rate of weight gain post SCI in the UK. An unpublished 
retrospective audit carried out amongst patients attending the outpatient clinic at the 
NSIC at Stoke Mandeville Hospital in 2007, showed that BMI increased by 2 kg/m
2
 for 
males and 3 kg/m
2
 for females after their SCI. When comparing this with the national 
survey data in the UK, (Henderson et al, 2003) patients with SCI (Gupta et al, 2006) 
seem more likely to become overweight and obese than the able-bodied population (60 
% vs. 40 %). If I extrapolate from these estimated figures, it is predicted that at least 
18,000 individuals with SCI may be overweight or obese in the UK.   
 
Many of these conditions relating to obesity could be managed or prevented by 
appropriate nutritional interventions. In 2006, the NICE published guidelines on 
managing overweight and obesity. (NICE, 2006a) They recommended a reduction in 
energy intake, following the eat-well plate set by the government, (Food Standard 
Agency, 2002) and increased physical activity in conjunction with behaviour 
modification support for obesity management. Although weight loss has been advocated 
as a primary treatment strategy for the condition, to date, little high quality evidence 
exists to support this concept in patients with SCI. (section 1.5.5) To our best 
knowledge, only two trials has been published on the effect of dietary intervention in 
obese SCI individuals. Chen’s study demonstrates that a carefully planned programme 
with restricted dietary intake and lifestyle modification could be an effective way to 
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reduce the body weight of obese SCI patients without compromising total lean body 
mass and overall health. (Chen et al, 2006) . I replicated Chen’s (Chen et al, 2006) idea 
in NSIC and reported that a simple weight management clinic proved to be able to help 
overweight SCI individuals to lose weight without compromising lean body mass 
(Wong et al., 2011).  The most important therapeutic finding of that study was that 
dietary intervention results in a clinically meaningful reduction of weight in overweight 
SCI individuals. Overall weight was reduced by 3.9 % in this study, a similar finding to 
that of the study by Chen and colleagues (3.8 %). (Chen et al, 2006) However, despite 
well-documented positive outcomes of bariatric surgery in ambulatory patients (NICE, 
2006a), little information (paper 4) is available to guide both clinician and patients 
regarding the choice of bariatric (weight loss) surgery despite the UK NICE guideline 
recommends if all non-surgical interventions have been tried without success, then 
bariatric surgery could be an option to consider for patients who are morbidly obese. 
(NICE, 2006a) 
 
In 2012, a morbidly obese patient with SCI underwent a gastric bypass surgery in a UK-
based SCI centre. Following bariatric surgery, the patient (Subject A: paraplegia) 
showed gradual functional and anthropometric improvement, over a period of 7 months, 
and the patient’s laboratory investigations were stable (Table3.2). Subject A was 
discharged with a prescription for a general multivitamin/mineral preparation, vitamin 
D and thiamine supplements. A structured follow-up dietary programme was put in 
place that included from the first two weeks (liquid diet), weeks 3-4 (puree diet), weeks 
5-6 (soft-texture) and then he progressed to a normal diet from week 7.  This was 
followed by 3 monthly, 6 monthly and annual follow-ups. For the first 7 months after 
surgery, subject A’s total weight loss was 32.4 kg. He also showed further functional 
improvement at the 18 months follow up. From the baseline, at 7 months and 18 
months:  6 minutes walking distance: 91, 144 and 190m and Berg balance score: 19 (2 
elbow crutch), 51 (2 elbow crutch) and 44 (one elbow crutch) suggesting a positive 
clinical improvement (mobility) after bariatric surgery.   
 
Two years after publishing the first report, in 2014, another SCI patient (Subject B: 
paraplegia) underwent bariatric surgery after reporting a weight gain from 126.5kg to 
134.3kg after her SCI. Subject B was 44 years old and had sustained a T10 incomplete 
paraplegia, AIS: B due to a fall. A laparoscopic Roux-en-Y gastric bypass was 
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successfully performed in May 2013 and Subject B was also discharged with a 
prescription for a general multivitamin/mineral preparation, vitamin D supplements and 
thiamine supplements. For the first 7-months after surgery the total weight loss was 22 
kg for Subject B, and again I successfully demonstrated that there were important 
clinical improvements  in both functional outcomes (6 minutes walking distance, Berg 
balance score),  anthropometric measurements (BMI, waist circumference, mid-upper 
arm circumference, triceps-skinfold thickness, mid-arm muscle circumference) and 
nutritional blood biochemistry (Lipid profile, blood glucose, HbA1c and other 
micronutrients) (Table 3.2).  
 
The main limitation was that the evidence generated from a case report may not be 
generalisable to all SCI patients. This case study report was published as I realised that 
there were valuable lessons to be shared to other SCI clinicians. While the feasibility of 
implementing a multidisciplinary and long-term approach remains challenging (paper 4 
and paper 5). The aim of this published case report was to demonstrate bariatric surgery 
could be an option for morbid obese SCI patients if all non-surgical interventions have 
been tried but unsuccessful. In addition, there is a potential for excellent control of 
measurement and complete description of the treatment when publishing. However, the 
prospective case report could suffer from the possibility that the case was managed 
differently from the usual care because of the desire to publish the results in the future. 
Ethics approval was not required as this was a case report, but written informed consent 
was obtained from patient and patient’s consultant (M. Belci) before data collection and 
case report publication. I acknowledge the provision of bariatric surgery to all patients 
with obesity would not be practical; however,  I should take into account the potential 
benefits of reducing/reversing comorbid conditions in order to ensure that bariatric 
surgery is as cost-effective an intervention as possible. I hope that the presentation of 
these cases will be useful to health-care professionals in dealing with similar cases. As 
discussed in section 2.2.1 and paper 4, the present study support the need for a practice 
guideline to help clinicians working in the SCI centres to manage obesity after SCI. 
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Table 3.2: Characteristics of subjects at baseline and 7 months after bariatric 
surgery 
Parameters Subject 1 Subject 2 
 Baseline 7-months 
after 
surgery 
% change Baseline 7-months 
after 
surgery 
% 
change 
Functional outcomes 
6-mins walking 
distance (m) 91 144 58 
N/A non 
walker 
N/A non 
walker 
N/A     
non 
walker 
Berg balance 
score 
19 51 168 N/A N/A N/A 
Anthropometric measurements 
Body mass 
index (kg/m
2
) 
59.8 49.8 16.7 48.3 40.8 15.5 
Waist-
circumference 
(cm) 
165 146 11.5 N/A N/A - 
Mid-upper arm 
circumference 
(cm) 
53.8 42 21.9 32.9 29.1 11.6 
Triceps-skin 
fold thickness 
(mm) 
43.8 20 54.3 41.6 36.2 12.9 
Mid-arm 
muscle 
circumference 
(cm) 
40 35.7 10.7 32.9 29.1 11.5 
Laboratory investigation 
Total 
cholesterol 
(mmol/L) 
4.5 3.5 22.2 4.4 4.1 6.8 
HDL-
cholesterol 
(mmol/L) 
1.1 1.2 9.1 1.4 1.4 - 
LDL-
cholesterol 
(mmol/L) 
2.7 1.8 33.3 1.7 1.5 11.8 
Triglycerides 
(mmol/L) 
1.5 1.1 26.7 1.7 1.5 11.8 
25 hydroxy-
vitamin D 
(nmol/L) 
20.6 33.9 64.5 30.8 68.9 123.7 
Folate (ng/ml) 1.4 16.9 1107 6.4 9.4 46.8 
Ferritin (ng/ml) 85 179 110 229 93 59.4 
Vitamin B12 
(pg/ml) 
250 274 9.6 701 422 39.8 
Abbreviations: HDL: High density lipoprotein; LDL: low-density lipoprotein 
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3.3 Use of probiotics Lactobacillus casei Shirota in Preventing AAD/CDI in SCI 
patients 
The evidence on the use of probiotic in preventing AAD / CDI in SCI patients is 
limited. (section 1.6.2) It appeared logical to assess the efficacy of probiotics in SCI 
patients because these patients are particularly vulnerable to infections and 
subsequently, AAD for many reasons. I therefore planned an open-labelled, randomised 
controlled trial to assess the efficacy of a commercial probiotic (LcS) for the prevention 
of AAD and CDI in adults with SCI. The objectives of this study were i) to determine 
the potential efficacy of LcS for the prevention of AAD and that caused by CDI for the 
duration of antibiotic use; and ii) to determine whether undernutrition-risk and the use 
of PPI are risk factors for AAD and CDI.   
 
In this section the impact of diarrhoea in SCI patients and risk factors for AAD and CDI 
are discussed, together with the efficacy of using probiotics for preventing AAD and 
CDI in SCI patients.  Papers 3 is used to support this section.  
 
Paper 3: Wong S et al. (2014) A Lactobacillus casei Shirota probiotic drink 
reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a 
randomised controlled trial. Br J Nutr 111, 672-678.  
 
I undertook an open-labelled RCT to assess the efficacy of a commercial probiotic 
(LcS) for the prevention of AAD and CDI in adults with a SCI.  Ethical approval was 
granted by the NRES Committee (Ref: 10/H0605/19) and approval from the local 
institution’s research board. Written informed consent was obtained from all patients 
before data collection and intervention. I randomized 158 SCI patients who required 
antibiotics; 76 received a commercially produced probiotic containing at least 6.5 × 10⁹ 
live LcS, and 82 received no probiotic. The probiotics were administered once daily 
during the antibiotic treatment and for 7 days afterward. The SNST was used to assess 
patient’s undernutrition risk (SNST score ≥11) at baseline, and 65% were found to be at 
risk for undernutrition. SCI patients (n=76) who took a commercial probiotic 
preparation of live LcS showed a significantly reduced risk of AAD when compared to 
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the control (no LcS) group (17.1 vs. 54.9%, p<0.001). Only one CDI (1.2%) was 
observed, and this was in the control group (n=82).  Other than probiotic consumption, 
there were no significant differences between the two groups in nutrient intake or the 
number of antibiotics used. The use of proton-pump inhibitors and the occurrence of 
CDI were similar in the two groups. The strongest risk factors for antibiotic-associated 
diarrhoea were undernutrition (64.1% vs 33.3%; P < .01) and the use of proton-pump 
inhibitors (38.4% vs 12.1%; P = .022). 
 
Our study also identified that poor appetite (nil by mouth), which can lead to under-
nutrition, is an independent risk factor for AAD (Paper 3). This is in line with our 
previous work that a significant number of patients tend to miss one or more of their 
hospital meals, and this can contribute to a substantial loss of energy and protein. 
(section 3.2: Paper 1) 
 
LcS was chosen as the probiotic for this study (Paper 3). To date there are no studies 
which have examined the effect of probiotics on the prevention of diarrhoea in SCI 
patients. Therefore it was logical to perform such an experiment using a commercially 
available probiotic at a relatively low cost. I acknowledge that this preparation is a 
‘commercial’ probiotic but it is important to note that the results of the study were not 
influenced by commercial considerations. 
 
There were some limitations associated with the un-blinded nature of the study.  Due to 
the lack of a true placebo for this trial, the use of a heat-treated LcS was considered 
while planning this study but the production and quality control requirements for this 
were not possible. Heat treatment may not have killed all of the bacteria and may have 
led to undesirable taste changes which would have affected compliance within the 
control group. Furthermore, heat-treated bacteria can have some immune-modulatory 
effects. Therefore, I had little choice but to elect to have an open-label study and to use 
no intervention for the control group. It should be noted that a recent study has also used 
the same design (Dong et al., 2013).    
 
Our study only collected nutrient intake as estimated by food record charts (nil by 
mouth, less than half, and half, more than half and all eaten), so it was not possible to 
perform individual dietary analysis. After taking an average of our hospital menu, I 
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compared patients’ nutrient intake, including total energy, protein and dietary fibre, but 
could not find any statistical difference between the two groups. The probiotic product I 
chose had an energy value of 114.2 kJ (27.3 kcal). As described, although under-
nutrition was common, I failed to identify any significant difference in nutrient intake in 
both groups. Therefore, I would not expect this extra 114.2 kJ to have made any 
significant impact, although this could be a potential limitation to our study. 
 
Our study (Paper 3) reports an encouragingly low incidence of CDI, probably reflecting 
the adoption of the protocol recommended by the UK Department of Health, which 
focuses on strict hygienic practices, strict antibiotic use, restricted use of laxatives and 
PPIs, and isolation wards for confirmed and suspected CDI. However, the numerical 
data does not contradict a possible additional benefit from LcS.  
 
I noted that our study found a higher incidence of AAD (36.1%) than in some previous 
reports (~25%) (Bartlett, 2002). This may be attributed to a longer follow up period (30 
days) than in many of the other published trials (often only 7-14 days) (Hickson, 2011), 
as diarrhoea may occur up to two months after discontinuing antibiotic treatment 
(McFarland, 2000).  
 
Furthermore, the nurses were not blinded to the group into which patients had been 
recruited but they were only aware if the patients were on LcS, and were not aware if 
patients had been recruited to the control group (routine care). All nurses were trained in 
using the Bristol Stool Scale and were only responsible for recording bowel motions 
according to the routine clinical procedure. The patients were not blinded to which arm 
they were being recruited into, and as lead researcher I too was not blinded to the study. 
The study outcome (occurrence of diarrhoea) was collected by the researcher according 
to an agreed definition from the clinical notes.  In the absence of a placebo, I believe 
this approach is sufficiently robust.   
 
Although this was not a double-blinded placebo RCT, there was an appropriate 
randomisation sequence, allocation concealment and the results were analysed on an 
intention-to-treat basis. Due to the limited number of trials in the literature, more 
research is required to determine if probiotics can reduce the incidence of AAD/CDI in 
SCI patients (Paper 3). 
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In conclusion, based on the present observation of a significant decrease in the 
incidence of AAD in patients with SCI, I can now consider LcS as a valid treatment 
option for the prevention of AAD in patients with SCI admitted to SCI centres. To 
confirm these findings and to evaluate the effectiveness of LcS in reducing the 
consequences of AAD/CDI, I am leading a multi-centre randomised placebo-controlled 
trial in the NSIC and Midland Centre of Spinal Injuries.  (Efficacy of Consuming LcS 
In Spinal cord injury Patients (ECLISP); ISRCTN13119162;  DOI 
10.1186/ISRCTN13119162) 
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Chapter 4 Discussion   
The research presented within this thesis sets out to achieve three key aims, the first to 
review and understand the vatiation in nutritional management in SCI centres. 
Secondly, to evaluate currently implemented nutrition interventions are based on sound 
research evidence and to discuss the potential limiting factors obstructing optimal 
nutrition practice in the SCI centres. Thirdly, to discuss whether nutritional 
interventions can improve SCI patient’s outcomes and finally, make recommendations 
for further research in SCI patients. 
 
In absence of a cure for SCI, research focuses on maximising a SCI patient’s quality of 
life and reducing complications secondary to SCI. Since Sir Guttmann opened the first 
SCI centre in Stoke Mandeville Hospital and introduced modern multidisciplinary and 
comprehensive SCI management, a SCI patient’s life expectancy has greatly improved 
(section 1.2.2). However, malnutrition, including under- and over- nutrition, becomes 
an apparent and unavoidable issue due to their enforced inactivity secondary to paralysis 
and subsequent change in body composition. Malnutrition is associated with increased 
morbidity, length of hospital stay and healthcare costs (section 2.3). Oral nutritional 
supplements (section 3.1), and artificial nutrition support are related to improved 
outcome, but have shown to mitigate the impact of patient’s clinical outcome (section 
1.5). The prescription of nutrition therapy by a dietitian can help in   matching SCI 
patient’s changing needs (section 1.4.2; section 3.3).    
 
I discussed that nutrition management practices vary considerably by countries (UK, the 
Netherlands, Belgium and Republic of Ireland). Various limiting factors in 
implementing evidence based nutritional interventions in SCI patients were discussed 
(section 2.4). These are mainly related to the poorly defined clinical outcomes such as  
definition of under- and over- nutrition risk after SCI (section 2.4.2); the definition of 
diarrhoea (section 2.4.2) and inadequate knowledge in managing malnutrition (section 
2.4.2). In addition, the lack of dietetic provision in SCI centres (section 1.3.3), will have 
a direct impact on availability of nutrition and dietetic expertise working in the SCI 
centre and to conduct clinical research.  I have reported several organisational factors, 
including sub-optimal dietetics and meal provision and poor nutritional knowledge 
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within these centres that are thought to contribute to the insufficient use of NSTs and a 
lack of inconsistency in providing adequate nutrition support needed for SCI patients.  
 
A key limitation to the survey studies (paper 4, 5, and 6) was the need to involve 
multidisciplinary staff’s engagement. The survey required responses from professionals 
to provide representation of team decisions across centres. Reflecting the size of the 
various centres, it captured more respondents from the larger centres and fewer 
respondents from the smaller centres. This may have influenced the results towards the 
action of the larger centres. However, we provided possible rationales in that I believe 
this may still be considered representative of clinical practice; The completion of the 
survey were all above 65%, and comparable to other published literatures, reflecting a 
high level of cooperation and participation and; staff who were less familiar with the 
clinical management of SCI patients may have excluded themselves, limiting the 
generalisability of results. 
 
The snowball methodology in selecting participants brings a potentially wide range of 
participants but does not allow for control over the number and type of participants, thus 
does not ensure representativeness of samples. (Faugier & Sargeant, 1997) 
Nevertheless, these surveys provide baseline data of current nutrition management of 
SCI patients in the UK, highlight differences in dietetic services and practice in the 
management of obesity in four European countries. The results from the survey studies 
strongly supported the need for SCI specific, evidence-based practice guidelines that 
can lead to improvement in care and patient health when implemented appropriately. 
These surveys could be repeated in future years to identify possible developments or 
progress in nutrition / obesity management in the UK.  
 
Ideally, it would have been valuable to target specific staff in particular centres to 
participate in the survey, but it was not possible to identify specific staff working in 
these centres, especially if they work across other services, as is often the case for 
dietitians. This relied on the sample being self-selective. To minimise bias, the survey 
was disseminated through a number of multi- and uni- professional networks (ISCOS 
and MASCIP).  
 
86 
The summary data are presented in this thesis as means and standard deviations (s.d) or 
median and range unless otherwise indicated. Missing data is an important factor that 
reduces the study power and worsens the precision of estimates. (Kang, 2013) In this 
thesis, the nutrition risk score, occurrence of diarrhoea, CDI are the main outcomes. The 
clinical measures including SCI level, AIS grade, weight, height, blood pressure, blood 
biochemistry were collected on admission or during the clinic visit. Participants who did 
not attend had their clinical, nutritional or biochemistry data measured on recruitment 
and follow up will result in missing values. One way of dealing with missing data is 
omitting that data, i.e. complete case analyses. However, by omitting subjects with any 
missing data, the study power is reduced, and the precision of the estimates could be 
worse.  In this thesis, missing data values were managed with multiple imputation using 
the SPSS (SPSS Inc, Birmingham, UK) Monte Carlo Markov Chain (MCMC) multiple 
imputation function. Thereafter, standard multiple imputation procedures were used to 
combine the multiple scalar and multivariate estimates quantities produced from the 
multiple analyses of the imputed datasets using SPSS version 19.0 (SPSS Inc, 
Birmingham, UK) to produce final results. Statistical and PhD supervisor (Dr. Shashi 
Hirani from University College London (2010), City, University of London (2011 
onwards) was available throughout the study period and helped with  the missing values 
imputation and the multivariate regression analysis. There were no missing data in 
respect of the primary end-points of the study in paper 3 (i.e. occurrence of AAD / 
CDI). 
I decided formal ethics review is not necessary for some of our paper (survey paper 1, 4, 
5 and 6) as these study is limited to secondary use of information previously collected in 
the course of normal care. The Health Research Authority also states the research ethic 
committee review is excluded when the study / research undertaken by staff within a 
care team using information previously collected in the course of care for their own 
patients and no patient identifiable data is used at any stage of the manuscript 
preparation. (The Health Research Authority, 2017) The above with discussed all 
participating centres in the UK and other European centre’s review board that formal 
ethics permission was not required. Although I did not perform sample size for our 
survey papers (1, 4, 5 and 6) as I believe the sample size represent a significant 
proportion of samples studied and comparable to other published studies. 
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There have been numerous clinical trials investigating the efficacy of nutrition 
intervention in general patients, however, there were limited trials in SCI patient with 
majority of these only including a small number of patients. Our reports (case-report; 
observational studies (surveys), systematic review, and RCT) are therefore to be 
welcomed; however, the study has a number of methodologic flaws that may impact on 
the validity of results.   
 
Without proper nutrition expertise in SCI centre, i.e. dietitian, the effectiveness of 
nutritional intervention will be difficult to implement and evaluate (such as use of 
probiotic in preventing AAD: section 3.3). SCI patients will receive poor evidence 
based clinical practice (section 2.4.4) ultimately, leading to poorer clinical outcomes 
and increased healthcare costs. An on-going initiative with the ISCOS, MASCIP and 
dietitians are underway to develop an evidence based clinical nutrition guideline in 
managing obesity after SCI. Through multidisciplinary collaboration, it is also expected 
to provide a practical solution to eliminate existing limitations, and disseminate new 
practice to clinicians working in the SCI centres. 
 
By following this body of work, I now have the potential limiting factors obstructing the 
implementation of good nutritional care in SCI centres and better understanding of what 
nutrition screening tool  should be used in SCI patients. In addition, a number of novel 
nutritional interventions / management approach were tested in SCI patients with a 
malnutrition-risk. The results of these studies indicated that it is possible to improve 
SCI patient’s clinical outcomes if nutrition care is embedded appropriately in the SCI 
centre’s policy.  
 
The key themes in this thesis are summarised in table 1.1 and the research findings have 
had an impact on the SCI centre’s practice. These include change in clinical practice, 
policy, organisational and development of new guideline. These are summarised in table 
4.1. This body of work will support the implementation of the SNST across UK SCI 
centres. Through proper nutrition screening, at risk individuals will then be referred for 
detailed nutrition assessment and nutritional intervention by the dietitian.  
 
88 
Table 4.1 Research impact                
Aim Author  Main outcomes   Research Impact   Clinical  Policy  Organisational Guideline  
Year         
Journal 
 
3 1.Wong et al  Nutrient intake often insufficient to  Further research on usage patterns          √     
2013  meet requirements and it likely to    of dietary supplements and potential  
J Spinal Cord Med is beneficial to use ONS and or VMS   health economic effect of dietary  
   To protect against and to treat  . supplements in SCI patients is needed 
   malnutrition 
 
 
1, 3 2. Wong et al I reported the first morbidly obese SCI Highlights that the provision of bariatric      √   √                 √             √ 
2013  patients who has undergone gastric bypass surgery as a option to consider if all               
Eur J Clin Nutr surgery      non-surgical interventions have been tried          
          
       Developemnt of clinical practice guideline: 
weight management guideline              
              
  
1, 3 3.Wong et al LcS could be consider as a valid measure for To confirm the findings and evaluate the        √  √   
2014  the prevention of AAD in SCI patients.  Effectiveness of LcS in preventing AAD 
Br J Nutr      and CDI, a larger placebo-controlled  
        Trial in different geographical location   
       is indicated. 
 
1, 2 4.Wong et al Limited knowledge among medical staff and Establishing multi-disclipinary SCI-specific     √  √                √ 
2015  variation in dietetic provision in SCI centre are weight management guideline 
Spinal Cord  probably barriers to effective weight management.  
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Theme Author  Main outcomes   Research Impact         Clinical  Policy  Organisational Guideline  
Year         
Journal 
 
 
 
1, 2 5.Wong et al The study highlighted staffing level varied across Further study is warranted to assess whether    √       √ 
2015  SCI centres and some are below professional  optimal dietetic resources could prevent 
Spinal Cord  recommendations   nutrition related complications 
    
 
 
1, 2 6.Wong et al Stocking probiotics for the prevention of Further effort in review the supporting  √  
2015  AAD / CDAD are not common.  Evidence for each probiotic before  
Int J Prob & Preb Definition of AAD / CDI are vary acroos stocking. 
  SCI centres    Systematic review on the effectiveness 
       of probiotic in preventing AAD / CDAD 
       in SCI patients is warranted. 
 
2 7.Wong et al  Systematic review protocol is published To carry out systematic review on the  √ 
2015      effectiveness of probiotic in preventing  
    Syst Rev      AAD / CDAD in SCI patients  
 
  
 
Aim 1: To review and understand the variations in nutritional management in SCI centres from the perspective of staff and SCI patients. 
Aim 2: To evaluate whether currently implemented nutrition interventions in SCI centres are based on sound research evidence, and potential barriers to good nutritional care in SCI centres.    
Aim 3: To report three original studies (from a case study to a randomised trial) that explore how  nutritional interventions may influence clinical outcomes in SCI patients. 
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4.1 Putting the results of this thesis into practice / research Impact 
To improve the accuracy of identifying at-risk patients, I recommend that the SCI centre 
should use the SNST as a measure to screen for malnutrition. The research in this thesis 
has resulted in a change of practice in SCI centres in the UK and beyond. The ISCOS 
has now incorporated the SNST as the choice of nutrition screening tool. The SNST is 
now being choice of Nutrition Screening Tool in six SCI centres in the UK and Ireland. 
All patients on admission will be nutritionally screened by the SNST and at-risk 
individuals will be referred to a dietitian for nutrition assessment and nutrition risk is 
required to be repeated at regular intervals.  
 
To help a SCI centre implement the use of SNST, I have developed a nutrition 
screening pathway for the centre’s reference (Figure 4.1). The aim of this pathway is to 
make sure there is equitable treatment across the UK SCI centres and that nutrition care 
is provided to malnourished patients with SCI.   
 
Locally, in the NSIC, I have successfully implemented the following projects within my 
practice. Since 2011:  
 Made nutrition screening training mandatory for all nursing staff when they join 
the NSIC. 
 Established a ward nutrition link nurse system, whereby ward dieticians provide 
in-depth training to the ward nutrition-link nurse who can then disseminate this 
to other clinicians involved in their care.  
 Have ensured that equipment (e.g. hoist scale/bed scale) is available, as this is 
one of the major barriers for nutrition screening. 
 To provide weekly and monthly update on nutrition screening compliance 
(performance indicator) to dietitians, ward and hospital management. (Wong et 
al, 2018) 
 
The results of this thesis and knowledge I acquired through my clinical practice and 
research have been shared with the national and international society for spinal cord 
injuries. I contributed in developing two sets of clinical guidelines (including the UK 
MASCIP older adult guidelines in 2009, and the ASIA pressure ulcer guidelines in 
2014), and was invited to contribute in three book chapters (The British Dietetic 
91 
Association’s Manual of Dietetic Practice in 2014, Advanced Nutrition and Dietetics in 
Nutrition Support in 2016, and the ISCOS textbook on the Comprehensive Management 
of Spinal Cord Injuries in 2015). In addition to publishing 18 peer-reviewed scientific 
journals, I have been asked to be a referee for 15 international peer-reviewed journals, 
including Clinical Nutrition, British Journal of Nutrition, Journal of Spinal Cord 
Medicine, Spinal Cord, Clinical Rehabilitation, the British Medical Journal, and 
Archives of Physical Medicine and Rehabilitation.  
 
To address the complex nutritional needs of this unique population group, I proposed 
the Specialised Clinical Commissioning Group to review the need to include a dietitian 
within the core SCI care team and I am pleased to report that dietetics is now included 
as part of the essential team for a SCI centre’s service within the NHS standard contract 
(NHS England, 2013). 
 
The wide dissemination of my work has also led to nominations to sit on the nutrition 
sub-committee of the ISCOS and other national bodies, including the Neuroscience 
Specialist Group of the British Dietetic Association and MASCIP). In recognition of my 
outstanding scientific contributions to the ISCOS official journal, Spinal Cord, I was 
awarded with the prestigious Silver Medal Spinal Cord Prize by the ISCOS in 
September 2012. The ISCOS, which has a membership of over 1,000 clinicians and 
scientists from 87 countries, awards the Spinal Cord Prize every two years to encourage 
its younger members to submit original work for publication. 
 
Following the publication of some of the research (paper 4; Wong et al, 2012e) included 
in this thesis, I have received invitations from local SCI consultants to address their staff 
training and also from the British Society of Rehabilitation Medicine and ISCOS to 
update their curriculum for nutrition for doctors in training. I am pleased to report that 
this has led to the inclusion of the first nutrition education module for doctors training in 
SCI, both locally and nationally. 
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1 
Paediatric: STMAP nutrition screening tool;     
  Adult: Spinal Nutrition Screening Tool 
2
 Nursing Nutrition care plan: In IMS / for further instruction – “Nutrition Care Plans How to.pdf”  
Frequency of re-screen / monitoring:  
Acute floor: weekly 
Rehab floor: monthly (routine screening); weekly if at-risk of malnutrition 
Further reference can refer to  
Guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children, NICE Clinical guideline 
43, 2006;  
NSIC Nutritional Pathway for children with Spinal Cord Injury;  
Spinal weight management pathway (adult);  
Prepared by Samford Wong on behalf of the NSIC nutrition group, Buckinghamshire Healthcare NHS Trust. Contact Tel: 01296315775 July 2012.  
 
Due 
for review 
July 2013 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Nutrition pathway for the National Spinal Injuries Centre   
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At a local hospital level, I have established the Spinal Nutrition and Dietetics research 
group in 2012 with the aim of gaining insight into the effectiveness of an optimised 
nutrition state via nutrition intervention in SCI patients. At the NSIC, dietetics itself 
consists of 3.73 whole-time-equivalent (WTE) staff; there are 1.83 WTE dieticians 
working in clinical areas and 1.6 WTE research dieticians (Figure4.2). This department 
represents a very important contribution to the clinical and academic development of 
spinal dietetics in the UK SCI centre, both nationally and internationally. The group 
maintains a strong collaborative stance within the Buckinghamshire Healthcare NHS 
Trust (clinical researchers and basic scientists) where it has many productive links, 
including with commercial organisations. There are joint research programme 
collaborations with Higher Education Institutes and NHS organisations.   
 
 
Figure 4.2: NSIC dietetic and research team organizational chart 
WTE: Whole time equivalent. 
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Figure 4.3: Collaborators diagram  
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Ideas, opinions, editorials, anecdotal: Book chapters  
Case series, case reports: Paper 2 
Cross-sectional studies: Paper 1, 4, 5 and 6 
Cohort studies / Case-control 
studies 
RCTs: Paper 3 
Sys Reviews 
Paper 7 
 
Since 2007, I have produced over 65 peer-reviewed abstracts, and have been privileged 
to present my work at various national and international meetings.  The research impact 
of my papers are summarised in Table 4.1 I have successfully completed six research 
projects, ranging from case report (paper 1), observation studies (survey paper 2, 4,5 
and 6) to randomised controlled trials (RCTs) (paper 3) and systematic review (protocol 
paper 7) helping me to develop as an independent clinical researcher.  Fig 4.4 and 4.5  
summarises the seven papers submitted for assessment and it’s critical appraisal 
summary (figure 4.5).  
 
Figure 4.4: Summary of studies presented for assessment
96 
Fig 4.5: Critical appraisal summary of the 7 studies presented for assessment 
 
RCT: randomised controlled trial 
SCI: spinal cord injury 
AAD: antibiotic associated diarrhoea 
CDI: Clostridium difficile infection 
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4.2 Conculsions and recommendations 
The studies covered in this thesis were originally conceived and developed from the 
perspective of a clinician (S. Wong) working in a specialised SCI centre with a 
background awareness of mixed practice for nutritional management across both district 
general hospitals and teaching hospitals.  Delayed admissions for those requiring 
specialist SCI interventions have increased over time in the UK due to growing demand 
and reduced bed capacity. Those with malnutrition often have correspondingly complex 
nutritional needs, requiring assessment and intervention by a specialist dietitian. 
Limited studies todate report the nutrition care of SCI patients in SCI centre. The 
primary research aim of the research was to review and understand the variations in 
nutritional resources and management in SCI centres in the UK and Republic of Ireland.  
 
Chapter 1.4 provides a review of the literature on the use of probiotics in preventing 
AAD and CDI. These studies are predominantly from general patients, therefore 
providing limited generalisability to SCI patients. Therefore the second aim was to 
evaluate whether the current implemented nutrition practice / interventions in SCI 
centres are based on sound research evidence and to evaluate the potential barriers to 
good nutritional care in SCI centres. I found variations in clinical management of AAD 
/ CDI; definition of malnutrition risk and diagnostic criteria of AAD / CDI in SCI 
patients across SCI centres. This was explored through a mailed survey of clinical staff 
working in SCI centres reported in chapter 2.4. The following study, chapter 3,3, 
reported the effectiveness on the use of a probiotic (LcS) in preventing AAD / CDI. In 
addition, a systematic review & meta-analysis protocol was devised to assess whether 
probiotics could prevent AAD / CDAD in SCI patients. The data from these studies 
would contribute to whether probiotic have a role in preventing AAD / CDI in SCI 
patients.  
 
The third and final aim of this thesis was to explore how nutritional interventions may 
influence clinical outcomes in SCI patients. Chapter 3.1 describes the use of nutritional 
supplements in patients at risk of undernutrition using a SCI-specific nutrition screening 
tool, the SNST. Chapter 3.2 describes the first UK bariatric surgery case in morbid 
obese SCI patients as a way to generate body weight loss who failed all other non-
surgical interventions. Chapter 3.3 reports the effectiveness of a commercial probiotic, 
LcS in preventing diarrhoea associated with antibiotics and CDI. The data from these 
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three studies would contribute evidence in the literature and would help to guide further 
recommendations for SCI management.  
 
The results from the studies presented in this thesis, have answered some of the 
questions addressed, but have also highlighted other issues that require further 
investigations. In this section, I will outline some possible future research directions. 
 
Research directions 
Malnutrition including both under- and over-nutrition has substantial adverse effects on 
health, disease and well-being in patients with SCI. Yet despite good evidence that 
specific efforts to correct the problems improve health outcomes, it appears that there 
are recurrent inconsistencies in the implementation of malnutrition screening. When 
malnutrition goes unrecognised and untreated, malnutrition also have a substantial 
impact on the health economy with increased demands on health services such as out of 
hours services and increased rates of transition across pathways of care. To tackle 
malnutrition after SCI effectively and efficiently, our body of work has recommended 
that malnutrition (under- and over-nutrition) risk needs to be screened, identified and 
managed appropriately. Further effort could focus on evaluating whether using group 
setting education rather than individual consultation could be a strategy to improve 
efficiency of service, particularly in the rehabilitation phase and weight management 
patients as this could help alleviate time and funding pressure. The development and 
implementation of NSTs for assessing nutrition-risk in SCI patients will facilitate a 
variety of projects, ranging from clinically based nutrition interventions studies to 
health economic studies, including an investigation of the cost of malnutrition in SCI 
patients. Furthermore, it is also indicated that the use of ONS and other evidence-based 
nutrition interventions should be promoted and recognised as an integral part of the 
management of SCI patients that require nutrition support, alongside food.   
 
After SCI, patients are particularly vulnerable to infections and subsequently, AAD for 
many reasons. Probiotic use could be a cost-effective intervention to prevent AAD, 
however, as probiotic effect is strain-specific, the effect of other strains is not known.  
A multi-centre study is underway to investigate the efficacy of probiotic LcS in 
preventing AAD / CDI in SCI patients using a randomised double-blinded, placebo-
controlled approach.   
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Without proper guidelines and training, it is unlikely that healthcare staff will have 
sufficient knowledge to identify at-risk patients or to offer appropriate treatment. Our 
work reinforces the need to consider collaborating with national professional bodies to 
develop SCI-specific weight management guidelines which include clear guidance on 
optimal dietetic service provision within the SCICs. In response to the need to develop 
specific clinical guidelines for SCI medical staff, the UK MASCIP has commissioned a 
multidisciplinary guidelines group to provide up-to-date information on overweight and 
obesity in SCI adults based on a systematic review of the literature.   
 
Conclusions  
This thesis has reported a range of studies using different methodologies from case 
studies to RCT and systematic review. (Figure 4.4) Although it has not included 
cohort/case-control studies, these have been described in my previous research work 
(Wong et al., 2011; Wong et al., 2012a). The body of work has demonstrated that it is 
possible to improve a SCI patient’s clinical outcomes if nutrition care is embedded in 
the SCI care-pathway. It has also raised a number of questions, provided a platform for 
subsequent research, and has pointed to several areas where further research could 
productively be directed to improve clinical practice within SCI care. 
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